WO2023153905A1 - Composition for organic optoelectronic diode, organic optoelectronic diode, and display device - Google Patents

Composition for organic optoelectronic diode, organic optoelectronic diode, and display device Download PDF

Info

Publication number
WO2023153905A1
WO2023153905A1 PCT/KR2023/002090 KR2023002090W WO2023153905A1 WO 2023153905 A1 WO2023153905 A1 WO 2023153905A1 KR 2023002090 W KR2023002090 W KR 2023002090W WO 2023153905 A1 WO2023153905 A1 WO 2023153905A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
substituted
unsubstituted
formula
independently
Prior art date
Application number
PCT/KR2023/002090
Other languages
French (fr)
Korean (ko)
Inventor
이병관
김윤수
신선웅
이미진
장기포
정성현
장진석
정호국
김병구
Original Assignee
삼성에스디아이 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 삼성에스디아이 주식회사 filed Critical 삼성에스디아이 주식회사
Publication of WO2023153905A1 publication Critical patent/WO2023153905A1/en

Links

Images

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • H10K85/633Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising polycyclic condensed aromatic hydrocarbons as substituents on the nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6574Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Definitions

  • It relates to a composition for an organic optoelectronic device, an organic optoelectronic device, and a display device.
  • An organic optoelectronic diode is a device capable of converting between electrical energy and light energy.
  • Organic optoelectronic devices can be largely divided into two types according to their operating principles.
  • One is a photoelectric device that generates electrical energy as excitons formed by light energy are separated into electrons and holes and the electrons and holes are transferred to different electrodes, respectively.
  • It is a light emitting device that generates light energy from
  • Examples of the organic optoelectronic device include an organic photoelectric device, an organic light emitting device, an organic solar cell, and an organic photo conductor drum.
  • OLEDs organic light emitting diodes
  • An organic light emitting device is a device that converts electrical energy into light, and the performance of the organic light emitting device is greatly affected by organic materials positioned between electrodes.
  • One embodiment provides a composition for an organic optoelectronic device capable of implementing a low-driving, high-efficiency, and long-life organic optoelectronic device.
  • Another embodiment provides an organic optoelectronic device including the compound.
  • Another embodiment provides a display device including the organic optoelectronic device.
  • a composition for an organic optoelectronic device including a first compound represented by Formula 1 below and a second compound represented by Formula 2 below is provided.
  • Ar 1 and Ar 2 are each independently a substituted or unsubstituted C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group;
  • L 1 to L 3 are each independently a single bond, a substituted or unsubstituted C6 to C30 arylene group or a substituted or unsubstituted C2 to C30 heteroarylene group,
  • R 1 to R 4 are each independently hydrogen, heavy hydrogen, a cyano group, a halogen group, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or An unsubstituted C2 to C30 heterocyclic group,
  • n1 is an integer from 1 to 3;
  • n2 and n3 are each independently an integer of 1 or 2;
  • n4 is an integer from 1 to 4.
  • Ar 3 and Ar 4 are each independently a substituted or unsubstituted C6 to C20 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group;
  • L 4 to L 6 are each independently a single bond or a substituted or unsubstituted C6 to C30 arylene group;
  • R 5 to R 9 are each independently hydrogen, heavy hydrogen, a cyano group, a halogen group, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or An unsubstituted C2 to C30 heterocyclic group,
  • n1 to m3 are each independently an integer of 0 or 1
  • n5 to n9 are each independently an integer of 1 to 4.
  • an organic optoelectronic device including an anode and a cathode facing each other, and at least one organic layer disposed between the anode and the cathode, wherein the organic layer includes the composition for an organic optoelectronic device.
  • a display device including the organic optoelectronic device is provided.
  • a low driving, high efficiency and long lifespan organic optoelectronic device can be implemented.
  • FIG. 1 is a cross-sectional view illustrating an organic light emitting device according to an exemplary embodiment.
  • substitution means that at least one hydrogen in a substituent or compound is deuterium, a halogen group, a hydroxyl group, an amino group, a substituted or unsubstituted C1 to C30 amine group, a nitro group, a substituted or Unsubstituted C1 to C40 silyl group, C1 to C30 alkyl group, C1 to C10 alkylsilyl group, C6 to C30 arylsilyl group, C3 to C30 cycloalkyl group, C3 to C30 heterocycloalkyl group, C6 to C30 aryl group, C2 to C30 A heteroaryl group, a C1 to C20 alkoxy group, a C1 to C10 trifluoroalkyl group, a cyano group, or a combination thereof.
  • substitution means that at least one hydrogen in a substituent or compound is deuterium, a C1 to C30 alkyl group, a C1 to C10 alkylsilyl group, a C6 to C30 arylsilyl group, a C3 to C30 cycloalkyl group, a C3 to C30 It means substituted with a heterocycloalkyl group, a C6 to C30 aryl group, a C2 to C30 heteroaryl group, or a cyano group.
  • substitution means that at least one hydrogen in a substituent or compound is substituted with deuterium, a C1 to C20 alkyl group, a C6 to C30 aryl group, or a cyano group.
  • substitution means that at least one hydrogen in a substituent or compound is substituted with deuterium, a C1 to C5 alkyl group, a C6 to C18 aryl group, or a cyano group.
  • substitution means that at least one hydrogen of a substituent or compound is substituted with deuterium, cyano group, methyl group, ethyl group, propyl group, butyl group, phenyl group, biphenyl group, terphenyl group or naphthyl group. means it has been
  • hetero means containing 1 to 3 heteroatoms selected from the group consisting of N, O, S, P and Si in one functional group, and the rest being carbon. .
  • aryl group is a general concept of a group having one or more hydrocarbon aromatic moieties, and all elements of the hydrocarbon aromatic moiety have p-orbitals, and these p-orbitals are conjugated Forming a form, for example, including a phenyl group, a naphthyl group, etc., including a form in which two or more hydrocarbon aromatic moieties are connected through a sigma bond, for example, a biphenyl group, a terphenyl group, a quaterphenyl group, etc., and two or more hydrocarbon aromatic moieties may include a non-aromatic fused ring in which they are directly or indirectly fused, such as a fluorenyl group and the like.
  • Aryl groups include monocyclic, polycyclic or fused-ring polycyclic (ie, rings having split adjacent pairs of carbon atoms) functional groups.
  • a heterocyclic group is a higher concept including a heteroaryl group, and in a ring compound such as an aryl group, a cycloalkyl group, a fused ring thereof, or a combination thereof, N, O, It means containing at least one heteroatom selected from the group consisting of S, P and Si.
  • the heterocyclic group is a fused ring, the entire heterocyclic group or each ring may include one or more heteroatoms.
  • heteroaryl group means containing at least one heteroatom selected from the group consisting of N, O, S, P, and Si in the aryl group.
  • Two or more heteroaryl groups may be directly connected through a sigma bond, or if the heteroaryl group includes two or more rings, the two or more rings may be fused to each other.
  • each ring may include 1 to 3 hetero atoms.
  • the substituted or unsubstituted C6 to C30 aryl group is a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthracenyl group, a substituted or unsubstituted phenanthrenyl group, a substituted or unsubstituted naphthyl group, or a substituted or unsubstituted phenanthrenyl group.
  • the substituted or unsubstituted C2 to C30 heterocyclic group is a substituted or unsubstituted furanyl group, a substituted or unsubstituted thiophenyl group, a substituted or unsubstituted pyrrolyl group, a substituted or unsubstituted pyrazolyl group, or a substituted or unsubstituted pyrazolyl group.
  • unsubstituted means that a hydrogen atom remains as a hydrogen atom without being substituted with another substituent.
  • hydrofluorescence substitution (-H) may include “deuterium substitution (-D)” or “tritium substitution (-T)”.
  • the hole characteristic refers to a characteristic that can form holes by donating electrons when an electric field is applied, and has conduction characteristics along the HOMO level, so that holes formed at the anode are injected into the light emitting layer, the light emitting layer It means a property that facilitates the movement of holes formed in the anode to the anode and in the light emitting layer.
  • electronic properties refer to the characteristics of receiving electrons when an electric field is applied, and has conductivity along the LUMO level, so that electrons formed in the cathode are injected into the light emitting layer, electrons formed in the light emitting layer move to the cathode, and in the light emitting layer A property that facilitates movement.
  • a composition for an organic optoelectronic device includes a first compound and a second compound.
  • the first compound is represented by Formula 1 below.
  • Ar 1 and Ar 2 are each independently a substituted or unsubstituted C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group;
  • L 1 to L 3 are each independently a single bond, a substituted or unsubstituted C6 to C30 arylene group or a substituted or unsubstituted C2 to C30 heteroarylene group,
  • R 1 to R 4 are each independently hydrogen, heavy hydrogen, a cyano group, a halogen group, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or An unsubstituted C2 to C30 heterocyclic group,
  • n1 is an integer from 1 to 3;
  • n2 and n3 are each independently an integer of 1 or 2
  • n4 is an integer from 1 to 4.
  • the first compound represented by Formula 1 is a structure in which amine is substituted for chrysene, and the long fused chrysene ring helps to stabilize the amine for holes and energy, which is advantageous for realizing a long-life device, and is particularly robust fused arylene Phosphorus Krysen is also very thermally stable.
  • Chemical Formula 1 may be represented by any one of Chemical Formulas 1-1 to 1-4.
  • Ar 1 , Ar 2 , L 1 to L 3 , R 1 to R 4 , and n1 to n4 are defined as described above.
  • Chemical Formula 1 may be represented by Chemical Formula 1-2.
  • Ar 1 and Ar 2 in Formula 1 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted terphenyl group, a substituted or unsubstituted naphthyl group, or a substituted or unsubstituted anthrayl group.
  • Cenyl group substituted or unsubstituted phenanthrenyl group, substituted or unsubstituted triphenylene group, substituted or unsubstituted dibenzofuranyl group, substituted or unsubstituted dibenzothiophenyl group, substituted or unsubstituted benzonaphtho It may be a furanyl group or a substituted or unsubstituted benzonaphthothiophenyl group.
  • Ar 1 and Ar 2 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted dibenzofuranyl group, or a substituted or unsubstituted dibenzofuranyl group. It may be a benzothiophenyl group, a substituted or unsubstituted benzonaphthofuranyl group, or a substituted or unsubstituted benzonaphthothiophenyl group.
  • L 1 to L 3 may each independently be a single bond, a substituted or unsubstituted phenylene group, or a substituted or unsubstituted naphthylene group.
  • L 1 in Formula 1 is a single bond
  • *-L 2 -Ar 1 and *-L 3 -Ar 2 may each independently be selected from substituents listed in Group I below.
  • the substituent may be unsubstituted or substituted with an additional substituent, and * is a linking point.
  • the additional substituent may be deuterium, a C1 to C5 alkyl group, or a C6 to C18 aryl group.
  • the first compound represented by Formula 1 may be one selected from compounds listed in Group 1 below, but is not limited thereto.
  • the second compound is represented by Formula 2 below.
  • Ar 3 and Ar 4 are each independently a substituted or unsubstituted C6 to C20 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group;
  • L 4 to L 6 are each independently a single bond or a substituted or unsubstituted C6 to C30 arylene group;
  • R 5 to R 9 are each independently hydrogen, heavy hydrogen, a cyano group, a halogen group, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or An unsubstituted C2 to C30 heterocyclic group,
  • n1 to m3 are each independently an integer of 0 or 1
  • n5 to n9 are each independently an integer of 1 to 4.
  • the second compound may be used together with the first compound in the light emitting layer to increase charge mobility and stability, thereby improving light emitting efficiency and lifetime characteristics.
  • Chemical Formula 2 may be represented by any one of Chemical Formulas 2A to 2D.
  • Ar 3 , Ar 4 , L 4 to L 6 , R 6 to R 9 , and n6 to n9 are defined as described above,
  • R 5a and R 5b are each independently selected from hydrogen, heavy hydrogen, a cyano group, a halogen group, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, or a substituted or unsubstituted C6 to C30 aryl group. Or a substituted or unsubstituted C2 to C30 heterocyclic group.
  • Ar 3 and Ar 4 in Formula 2 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted terphenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted biphenyl group, or a substituted or unsubstituted naphthyl group.
  • substituted anthracenyl group substituted or unsubstituted phenanthrenyl group, substituted or unsubstituted triphenylene group, substituted or unsubstituted dibenzofuranyl group, substituted or unsubstituted dibenzothiophenyl group, substituted or unsubstituted It may be a substituted or unsubstituted benzonaphthofuranyl group or a substituted or unsubstituted benzonaphthothiophenyl group.
  • Ar 3 and Ar 4 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted dibenzofuranyl group, a substituted or unsubstituted dibenzofuranyl group, or a substituted or unsubstituted biphenyl group.
  • benzonaphthofuranyl group may be a substituted or unsubstituted benzonaphthothiophenyl group.
  • L 4 to L 6 in Formula 2 may each independently be a single bond, a substituted or unsubstituted phenylene group, or a substituted or unsubstituted naphthylene group.
  • L 4 in Formula 2 is a single bond
  • *-L 5 -Ar 3 and *-L 6 -Ar 4 may each independently be selected from substituents listed in Group II below.
  • the substituent may be unsubstituted or substituted with an additional substituent, and * is a linking point.
  • the additional substituent may be deuterium, a C1 to C5 alkyl group, or a C6 to C18 aryl group.
  • the second compound may be one selected from compounds listed in Group 2 below, but is not limited thereto.
  • the first compound is represented by Formula 1-2,
  • the second compound may be represented by any one of Chemical Formulas 2B to 2C.
  • the first compound and the second compound may be included in a weight ratio of, for example, 1:99 to 99:1.
  • efficiency and lifespan can be improved by implementing bipolar characteristics by setting an appropriate weight ratio using the hole transport capability of the first compound and the electron transport capability of the second compound.
  • it may be included in a weight ratio of about 10:90 to 90:10, about 20:80 to 80:20, for example, about 20:80 to about 70:30, about 20:80 to about 60:40, And it may be included in a weight ratio of about 20:80 to about 50:50.
  • it may be included in a weight ratio of 20:80, 30:70, or 40:60.
  • one or more compounds may be further included.
  • composition for an organic optoelectronic device may further include a dopant.
  • the dopant may be, for example, a phosphorescent dopant, for example, a red, green or blue phosphorescent dopant, and may be, for example, a red or green phosphorescent dopant.
  • a dopant is a material that causes light emission by being mixed in a small amount in a composition for an organic optoelectronic device, and a material such as a metal complex that emits light by multiple excitation that is excited in a triplet state or higher may be used.
  • the dopant may be, for example, an inorganic, organic, or organic-inorganic compound, and may include one type or two or more types.
  • an example of the dopant may include a phosphorescent dopant, and examples of the phosphorescent dopant include Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, Tm, Fe, Co, Ni, Ru, Rh, Pd, or a combination thereof.
  • Organometallic compounds containing As the phosphorescent dopant for example, a compound represented by Chemical Formula Z may be used, but is not limited thereto.
  • M is a metal
  • L 7 and X are the same as or different from each other and are ligands that form a complex with M.
  • M may be, for example, Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, Tm, Fe, Co, Ni, Ru, Rh, Pd, or a combination thereof, and L 7 and X may be, for example, biden It may be a tate ligand.
  • Examples of the ligand represented by L 7 and X may be selected from the formulas listed in Group A below, but are not limited thereto.
  • R 300 to R 302 are each independently hydrogen, deuterium, a C1 to C30 alkyl group with or without halogen substitution, a C6 to C30 aryl group with or without C1 to C30 alkyl substitution, or halogen;
  • R 303 to R 324 are each independently hydrogen, deuterium, halogen, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C1 to C30 alkoxy group, a substituted or unsubstituted C3 to C30 cycloalkyl group, or a substituted Or an unsubstituted C2 to C30 alkenyl group, a substituted or unsubstituted C6 to C30 aryl group, a substituted or unsubstituted C1 to C30 heteroaryl group, a substituted or unsubstituted C1 to C30 amino group, a substituted or unsubstituted C6 to C30 arylamino group, SF 5 , a trialkylsilyl group having a substituted or unsubstituted C1 to C30 alkyl group, a dialkylarylsilyl group having a substituted or unsubstituted C1
  • a dopant represented by Chemical Formula V below may be included.
  • R 101 to R 116 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, a substituted or unsubstituted C6 to C20 aryl group, or -SiR 132 R 133 R 134 ;
  • R 132 to R 134 are each independently a C1 to C6 alkyl group
  • At least one of R 101 to R 116 is a functional group represented by Formula V-1 below;
  • L 100 is a bidentate ligand of a monovalent anion, and is a ligand that coordinates with iridium through an unshared electron pair of a carbon or heteroatom,
  • n1 and n2 are independently any one of integers from 0 to 3
  • n1 + n2 is any one of integers from 1 to 3
  • R 135 to R 139 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, a substituted or unsubstituted C6 to C20 aryl group, or -SiR 132 R 133 R 134 ;
  • a dopant represented by Chemical Formula Z-1 may be included.
  • rings A, B, C, and D each independently represent a 5- or 6-membered carbocyclic or heterocyclic ring;
  • R A , R B , R C , and R D each independently represent mono-, di-, tri-, or tetra-substituted, or unsubstituted;
  • nA is 0, L E is not present;
  • a dopant according to an embodiment may be a platinum complex, and may be represented by Chemical Formula VI below.
  • X 100 is selected from O, S and NR 131 ;
  • R 117 to R 131 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, a substituted or unsubstituted C6 to C20 aryl group, or - SiR 132 R 133 R 134 ;
  • R 132 to R 134 are each independently a C1 to C6 alkyl group
  • At least one of R 117 to R 131 is -SiR 132 R 133 R 134 or a tert-butyl group.
  • organic optoelectronic devices to which the above-described composition for organic optoelectronic devices is applied will be described.
  • the organic optoelectronic device is not particularly limited as long as it is a device capable of converting electrical energy and light energy, and examples thereof include an organic photoelectric device, an organic light emitting device, an organic solar cell, and an organic photoreceptor drum.
  • FIG. 1 is a cross-sectional view showing an organic light emitting device according to an exemplary embodiment.
  • an organic light emitting device 100 includes an anode 120 and a cathode 110 facing each other, and an organic layer 105 positioned between the anode 120 and the cathode 110.
  • the anode 120 may be made of, for example, a conductor having a high work function so as to smoothly inject holes, and may be made of, for example, metal, metal oxide, and/or conductive polymer.
  • the anode 120 may be formed of, for example, a metal such as nickel, platinum, vanadium, chromium, copper, zinc, or gold or an alloy thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO and Al or SnO 2 and Sb; conductive polymers such as poly(3-methylthiophene), poly(3,4-(ethylene-1,2-dioxy)thiophene) (polyehtylenedioxythiophene: PEDOT), polypyrrole, and polyaniline; It is not.
  • the cathode 110 may be made of, for example, a conductor having a low work function so as to facilitate electron injection, and may be made of, for example, metal, metal oxide, and/or conductive polymer.
  • the negative electrode 110 may be formed of, for example, metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, lead, cesium, barium, or alloys thereof; Multi-layered materials such as LiF/Al, LiO 2 /Al, LiF/Ca, and BaF 2 /Ca may be mentioned, but are not limited thereto.
  • the organic layer 105 may include the above-described composition for an organic optoelectronic device.
  • the organic layer 105 includes the light emitting layer 130, and the light emitting layer 130 may include the above-described composition for an organic optoelectronic device.
  • composition for an organic optoelectronic device further comprising a dopant may be, for example, a red or green light emitting composition.
  • the light emitting layer 130 may include, for example, the aforementioned composition for an organic optoelectronic device as a phosphorescent host.
  • the organic layer may further include a charge transport region in addition to the light emitting layer.
  • the charge transport region may be, for example, the hole transport region 140 .
  • the hole transport region 140 may further increase hole injection and/or hole mobility between the anode 120 and the light emitting layer 130 and block electrons.
  • the hole transport region 140 may include a hole transport layer between the anode 120 and the light emitting layer 130, and a hole transport auxiliary layer between the light emitting layer 130 and the hole transport layer. At least one of the listed compounds may be included in at least one of the hole transport layer and the hole transport auxiliary layer.
  • the charge transport region may be, for example, the electron transport region 150 .
  • the electron transport region 150 may further increase electron injection and/or electron mobility between the cathode 110 and the light emitting layer 130 and block holes.
  • the electron transport region 150 may include an electron transport layer between the cathode 110 and the light emitting layer 130, and an electron transport auxiliary layer between the light emitting layer 130 and the electron transport layer. At least one of the listed compounds may be included in at least one of the electron transport layer and the electron transport auxiliary layer.
  • One embodiment may be an organic light emitting device including a light emitting layer as an organic layer.
  • Another embodiment may be an organic light emitting device including a light emitting layer and a hole transport region as an organic layer.
  • Another embodiment may be an organic light emitting device including an emission layer and an electron transport region as an organic layer.
  • an organic light emitting device may include a hole transport region 140 and an electron transport region 150 in addition to the emission layer 130 as the organic layer 105 .
  • the organic light emitting device may further include an electron injection layer (not shown), a hole injection layer (not shown), and the like in addition to the light emitting layer as the organic layer described above.
  • an organic layer is formed by a dry film method such as evaporation, sputtering, plasma plating, or ion plating, and then a cathode or cathode thereon. It can be manufactured by forming an anode.
  • the organic light emitting device described above may be applied to an organic light emitting display device.
  • a compound presented as a more specific example of the compound of the present invention was synthesized through the following steps.
  • A-79-1 and int-2 were synthesized in the same manner as in Synthesis Example 1 for the synthesis of compound A-69 using int-2 as starting materials, and recrystallized with toluene to obtain compound A-79. (Yield: 59.8%)
  • a glass substrate coated with ITO Indium tin oxide
  • ITO Indium tin oxide
  • the substrate was ultrasonically cleaned with a solvent such as isopropyl alcohol, acetone, or methanol, dried, transferred to a plasma cleaner, cleaned for 10 minutes using oxygen plasma, and then transferred to a vacuum evaporator.
  • compound A doped with 3% NDP-9 commercially available from Novaled was vacuum deposited on the ITO substrate to form a hole injection layer having a thickness of 100 ⁇ , and the hole injection layer Compound A was deposited to a thickness of 1350 ⁇ on top to form a hole transport layer.
  • Compound B was deposited on top of the hole transport layer to a thickness of 350 ⁇ to form a hole transport auxiliary layer, and Compound A-69 obtained in Synthesis Example 1 and Compound B-4 obtained in Synthesis Example 10 were used as hosts on the hole transport auxiliary layer. and 10wt% PhGD was doped as a dopant to form a light emitting layer having a thickness of 400 ⁇ by vacuum deposition, where Compound A-69 and Compound B-4 were used in a weight ratio of 5:5.
  • compound C was deposited on the light emitting layer to a thickness of 50 ⁇ to form an electron transport auxiliary layer, and compound D and Liq were simultaneously vacuum deposited in a weight ratio of 1: 1 to form an electron transport layer with a thickness of 300 ⁇ .
  • An organic light emitting device was fabricated by forming a cathode by sequentially vacuum depositing 15 ⁇ of LiQ and 1200 ⁇ of Al on the electron transport layer.
  • the result was obtained by measuring the luminance of the manufactured organic light emitting device using a luminance meter (Minolta Cs-1000A) while increasing the voltage from 0V to 10V.
  • Luminous efficiency (cd/A) of the same current density (10 mA/cm 2 ) was calculated using the luminance and current density measured from (1) and (2) above.
  • the initial luminance (cd/m 2 ) was emitted at 24,000 cd/m 2 using the Polaronics lifetime measurement system, and the decrease in luminance over time was measured, and the luminance was 95% compared to the initial luminance.
  • the reduced time point was measured as the T95 lifetime.
  • the result was obtained by measuring the driving voltage of each device at 15 mA/cm 2 using a current-voltmeter (Keithley 2400).
  • the organic light emitting device to which the compound according to the embodiment of the present invention is applied has improved drive, efficiency, and lifespan characteristics compared to the organic light emitting device according to the comparative example, and in particular, lifespan characteristics are remarkably improved.

Abstract

The present invention relates to: a composition for an organic optoelectronic diode, comprising a first compound represented by chemical formula 1 and a second compound represented by chemical formula 2; and an organic optoelectronic diode and a display device, comprising same. The details of chemical formulas 1 and 2 are as defined in the specification.

Description

유기 광전자 소자용 조성물, 유기 광전자 소자 및 표시 장치Compositions for organic optoelectronic devices, organic optoelectronic devices and display devices
유기 광전자 소자용 조성물, 유기 광전자 소자 및 표시 장치에 관한 것이다.It relates to a composition for an organic optoelectronic device, an organic optoelectronic device, and a display device.
유기 광전자 소자(organic optoelectronic diode)는 전기 에너지와 광 에너지를 상호 전환할 수 있는 소자이다.An organic optoelectronic diode is a device capable of converting between electrical energy and light energy.
유기 광전자 소자는 동작 원리에 따라 크게 두 가지로 나눌 수 있다. 하나는 광 에너지에 의해 형성된 엑시톤(exciton)이 전자와 정공으로 분리되고 전자와 정공이 각각 다른 전극으로 전달되면서 전기 에너지를 발생하는 광전 소자이고, 다른 하나는 전극에 전압 또는 전류를 공급하여 전기 에너지로부터 광 에너지를 발생하는 발광 소자이다. Organic optoelectronic devices can be largely divided into two types according to their operating principles. One is a photoelectric device that generates electrical energy as excitons formed by light energy are separated into electrons and holes and the electrons and holes are transferred to different electrodes, respectively. It is a light emitting device that generates light energy from
유기 광전자 소자의 예로는 유기 광전 소자, 유기 발광 소자, 유기 태양 전지 및 유기 감광체 드럼(organic photo conductor drum) 등을 들 수 있다. Examples of the organic optoelectronic device include an organic photoelectric device, an organic light emitting device, an organic solar cell, and an organic photo conductor drum.
이 중, 유기 발광 소자(organic light emitting diode, OLED)는 근래 평판 표시 장치(flat panel display device)의 수요 증가에 따라 크게 주목받고 있다. 유기 발광 소자는 전기 에너지를 빛으로 전환시키는 소자로서, 유기 발광 소자의 성능은 전극 사이에 위치하는 유기 재료에 의해 많은 영향을 받는다. Among them, organic light emitting diodes (OLEDs) have recently been attracting great attention due to an increase in demand for flat panel display devices. An organic light emitting device is a device that converts electrical energy into light, and the performance of the organic light emitting device is greatly affected by organic materials positioned between electrodes.
일 구현예는 저구동, 고효율 및 장수명 유기 광전자 소자를 구현할 수 있는 유기 광전자 소자용 조성물을 제공한다.One embodiment provides a composition for an organic optoelectronic device capable of implementing a low-driving, high-efficiency, and long-life organic optoelectronic device.
다른 구현예는 상기 화합물을 포함하는 유기 광전자 소자를 제공한다.Another embodiment provides an organic optoelectronic device including the compound.
또 다른 구현예는 상기 유기 광전자 소자를 포함하는 표시 장치를 제공한다.Another embodiment provides a display device including the organic optoelectronic device.
일 구현예에 따르면, 하기 화학식 1로 표시되는 제1 화합물, 및 하기 화학식 2로 표시되는 제2 화합물을 포함하는 유기 광전자 소자용 조성물을 제공한다.According to one embodiment, a composition for an organic optoelectronic device including a first compound represented by Formula 1 below and a second compound represented by Formula 2 below is provided.
[화학식 1][Formula 1]
Figure PCTKR2023002090-appb-img-000001
Figure PCTKR2023002090-appb-img-000001
상기 화학식 1에서,In Formula 1,
Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,Ar 1 and Ar 2 are each independently a substituted or unsubstituted C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group;
L1 내지 L3은 각각 독립적으로 단일 결합, 치환 또는 비치환된 C6 내지 C30 아릴렌기 또는 치환 또는 비치환된 C2 내지 C30 헤테로아릴렌기이며,L 1 to L 3 are each independently a single bond, a substituted or unsubstituted C6 to C30 arylene group or a substituted or unsubstituted C2 to C30 heteroarylene group,
R1 내지 R4는 각각 독립적으로 수소, 중수소, 시아노기, 할로겐기, 치환 또는 비치환된 아민기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,R 1 to R 4 are each independently hydrogen, heavy hydrogen, a cyano group, a halogen group, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or An unsubstituted C2 to C30 heterocyclic group,
n1은 1 내지 3의 정수 중 하나이고,n1 is an integer from 1 to 3;
n2 및 n3은 각각 독립적으로 1 또는 2의 정수 중 하나이며,n2 and n3 are each independently an integer of 1 or 2;
n4는 1 내지 4의 정수 중 하나이고;n4 is an integer from 1 to 4;
[화학식 2][Formula 2]
Figure PCTKR2023002090-appb-img-000002
Figure PCTKR2023002090-appb-img-000002
상기 화학식 2에서,In Formula 2,
Ar3 및 Ar4는 각각 독립적으로 치환 또는 비치환된 C6 내지 C20 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,Ar 3 and Ar 4 are each independently a substituted or unsubstituted C6 to C20 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group;
L4 내지 L6은 각각 독립적으로 단일결합 또는 치환 또는 비치환된 C6 내지 C30 아릴렌기이고, L 4 to L 6 are each independently a single bond or a substituted or unsubstituted C6 to C30 arylene group;
R5 내지 R9는 각각 독립적으로 수소, 중수소, 시아노기, 할로겐기, 치환 또는 비치환된 아민기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,R 5 to R 9 are each independently hydrogen, heavy hydrogen, a cyano group, a halogen group, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or An unsubstituted C2 to C30 heterocyclic group,
m1 내지 m3 은 각각 독립적으로 0 또는 1의 정수이고,m1 to m3 are each independently an integer of 0 or 1,
0 ≤ m1+m2+m3 ≤ 1이며,0 ≤ m1+m2+m3 ≤ 1, and
n5 내지 n9는 각각 독립적으로 1 내지 4의 정수 중 하나이다.n5 to n9 are each independently an integer of 1 to 4;
다른 구현예에 따르면, 서로 마주하는 양극과 음극, 상기 양극과 상기 음극 사이에 위치하는 적어도 1층의 유기층을 포함하고, 상기 유기층은 상기 유기 광전자 소자용 조성물을 포함하는 유기 광전자 소자를 제공한다.According to another embodiment, an organic optoelectronic device including an anode and a cathode facing each other, and at least one organic layer disposed between the anode and the cathode, wherein the organic layer includes the composition for an organic optoelectronic device.
또 다른 구현예에 따르면, 상기 유기 광전자 소자를 포함하는 표시 장치를 제공한다.According to another embodiment, a display device including the organic optoelectronic device is provided.
저구동, 고효율 및 장수명 유기 광전자 소자를 구현할 수 있다.A low driving, high efficiency and long lifespan organic optoelectronic device can be implemented.
도 1은 일 구현예에 따른 유기 발광 소자를 도시한 단면도이다.1 is a cross-sectional view illustrating an organic light emitting device according to an exemplary embodiment.
<부호의 설명><Description of codes>
100: 유기 발광 소자100: organic light emitting element
105: 유기층105 organic layer
110: 음극110: cathode
120: 양극120: anode
130: 발광층130: light emitting layer
140: 정공수송영역140: hole transport region
150: 전자수송영역150: electron transport area
이하, 본 발명의 구현예를 상세히 설명하기로 한다. 다만, 이는 예시로서 제시되는 것으로, 이에 의해 본 발명이 제한되지는 않으며 본 발명은 후술할 청구범위의 범주에 의해 정의될 뿐이다.Hereinafter, embodiments of the present invention will be described in detail. However, this is presented as an example, and the present invention is not limited thereby, and the present invention is only defined by the scope of the claims to be described later.
본 명세서에서 "치환"이란 별도의 정의가 없는 한, 치환기 또는 화합물 중의 적어도 하나의 수소가 중수소, 할로겐기, 히드록실기, 아미노기, 치환 또는 비치환된 C1 내지 C30 아민기, 니트로기, 치환 또는 비치환된 C1 내지 C40 실릴기, C1 내지 C30 알킬기, C1 내지 C10 알킬실릴기, C6 내지 C30 아릴실릴기, C3 내지 C30 시클로알킬기, C3 내지 C30 헤테로시클로알킬기, C6 내지 C30 아릴기, C2 내지 C30 헤테로아릴기, C1 내지 C20 알콕시기, C1 내지 C10 트리플루오로알킬기, 시아노기, 또는 이들의 조합으로 치환된 것을 의미한다. In this specification, unless otherwise defined, "substitution" means that at least one hydrogen in a substituent or compound is deuterium, a halogen group, a hydroxyl group, an amino group, a substituted or unsubstituted C1 to C30 amine group, a nitro group, a substituted or Unsubstituted C1 to C40 silyl group, C1 to C30 alkyl group, C1 to C10 alkylsilyl group, C6 to C30 arylsilyl group, C3 to C30 cycloalkyl group, C3 to C30 heterocycloalkyl group, C6 to C30 aryl group, C2 to C30 A heteroaryl group, a C1 to C20 alkoxy group, a C1 to C10 trifluoroalkyl group, a cyano group, or a combination thereof.
본 발명의 일 예에서, "치환"은 치환기 또는 화합물 중의 적어도 하나의 수소가 중수소, C1 내지 C30 알킬기, C1 내지 C10 알킬실릴기, C6 내지 C30 아릴실릴기, C3 내지 C30 시클로알킬기, C3 내지 C30 헤테로시클로알킬기, C6 내지 C30 아릴기, C2 내지 C30 헤테로아릴기, 또는 시아노기로 치환된 것을 의미한다. 또한, 본 발명의 구체적인 일 예에서, "치환"은 치환기 또는 화합물 중의 적어도 하나의 수소가 중수소, C1 내지 C20 알킬기, C6 내지 C30 아릴기, 또는 시아노기로 치환된 것을 의미한다. 또한, 본 발명의 구체적인 일 예에서, "치환"은 치환기 또는 화합물 중의 적어도 하나의 수소가 중수소, C1 내지 C5 알킬기, C6 내지 C18 아릴기, 시아노기로 치환된 것을 의미한다. 또한, 본 발명의 구체적인 일 예에서, "치환"은 치환기 또는 화합물 중의 적어도 하나의 수소가 중수소, 시아노기, 메틸기, 에틸기, 프로필기, 부틸기, 페닐기, 바이페닐기, 터페닐기 또는 나프틸기로 치환된 것을 의미한다. In one example of the present invention, "substitution" means that at least one hydrogen in a substituent or compound is deuterium, a C1 to C30 alkyl group, a C1 to C10 alkylsilyl group, a C6 to C30 arylsilyl group, a C3 to C30 cycloalkyl group, a C3 to C30 It means substituted with a heterocycloalkyl group, a C6 to C30 aryl group, a C2 to C30 heteroaryl group, or a cyano group. In addition, in a specific example of the present invention, "substitution" means that at least one hydrogen in a substituent or compound is substituted with deuterium, a C1 to C20 alkyl group, a C6 to C30 aryl group, or a cyano group. In addition, in a specific example of the present invention, "substitution" means that at least one hydrogen in a substituent or compound is substituted with deuterium, a C1 to C5 alkyl group, a C6 to C18 aryl group, or a cyano group. In addition, in a specific example of the present invention, "substitution" means that at least one hydrogen of a substituent or compound is substituted with deuterium, cyano group, methyl group, ethyl group, propyl group, butyl group, phenyl group, biphenyl group, terphenyl group or naphthyl group. means it has been
본 명세서에서 "헤테로"란 별도의 정의가 없는 한, 하나의 작용기 내에 N, O, S, P 및 Si로 이루어진 군에서 선택되는 헤테로 원자를 1 내지 3개 함유하고, 나머지는 탄소인 것을 의미한다.In this specification, unless otherwise defined, "hetero" means containing 1 to 3 heteroatoms selected from the group consisting of N, O, S, P and Si in one functional group, and the rest being carbon. .
본 명세서에서 "아릴(aryl)기"는 탄화수소 방향족 모이어티를 하나 이상 갖는 그룹을 총괄하는 개념으로서, 탄화수소 방향족 모이어티의 모든 원소가 p-오비탈을 가지면서, 이들 p-오비탈이 공액(conjugation)을 형성하고 있는 형태, 예컨대 페닐기, 나프틸기 등을 포함하고, 2 이상의 탄화수소 방향족 모이어티들이 시그마 결합을 통하여 연결된 형태, 예컨대 바이페닐기, 터페닐기, 쿼터페닐기 등을 포함하며, 2 이상의 탄화수소 방향족 모이어티들이 직접 또는 간접적으로 융합된 비방향족 융합 고리, 예컨대 플루오레닐기 등을 포함할 수 있다.In the present specification, "aryl group" is a general concept of a group having one or more hydrocarbon aromatic moieties, and all elements of the hydrocarbon aromatic moiety have p-orbitals, and these p-orbitals are conjugated Forming a form, for example, including a phenyl group, a naphthyl group, etc., including a form in which two or more hydrocarbon aromatic moieties are connected through a sigma bond, for example, a biphenyl group, a terphenyl group, a quaterphenyl group, etc., and two or more hydrocarbon aromatic moieties may include a non-aromatic fused ring in which they are directly or indirectly fused, such as a fluorenyl group and the like.
아릴기는 모노시클릭, 폴리시클릭 또는 융합 고리 폴리시클릭(즉, 탄소원자들의 인접한 쌍들을 나눠 가지는 고리) 작용기를 포함한다.Aryl groups include monocyclic, polycyclic or fused-ring polycyclic (ie, rings having split adjacent pairs of carbon atoms) functional groups.
본 명세서에서 "헤테로고리기(heterocyclic group)"는 헤테로아릴기를 포함하는 상위 개념으로서, 아릴기, 시클로알킬기, 이들의 융합고리 또는 이들의 조합과 같은 고리 화합물 내에 탄소 (C) 대신 N, O, S, P 및 Si로 이루어진 군에서 선택되는 헤테로 원자를 적어도 한 개 함유하는 것을 의미한다. 상기 헤테로고리기가 융합고리인 경우, 상기 헤테로고리기 전체 또는 각각의 고리마다 헤테로 원자를 한 개 이상 포함할 수 있다.In the present specification, a "heterocyclic group" is a higher concept including a heteroaryl group, and in a ring compound such as an aryl group, a cycloalkyl group, a fused ring thereof, or a combination thereof, N, O, It means containing at least one heteroatom selected from the group consisting of S, P and Si. When the heterocyclic group is a fused ring, the entire heterocyclic group or each ring may include one or more heteroatoms.
일 예로 "헤테로아릴(heteroaryl)기"는 아릴기 내에 N, O, S, P 및 Si로 이루어진 군에서 선택되는 헤테로 원자를 적어도 한 개 함유하는 것을 의미한다. 2 이상의 헤테로아릴기는 시그마 결합을 통하여 직접 연결되거나, 상기 헤테로아릴기가 2 이상의 고리를 포함할 경우, 2 이상의 고리들은 서로 융합될 수 있다. 상기 헤테로아릴기가 융합고리인 경우, 각각의 고리마다 상기 헤테로 원자를 1 내지 3개 포함할 수 있다.For example, "heteroaryl group" means containing at least one heteroatom selected from the group consisting of N, O, S, P, and Si in the aryl group. Two or more heteroaryl groups may be directly connected through a sigma bond, or if the heteroaryl group includes two or more rings, the two or more rings may be fused to each other. When the heteroaryl group is a fused ring, each ring may include 1 to 3 hetero atoms.
보다 구체적으로, 치환 또는 비치환된 C6 내지 C30 아릴기는, 치환 또는 비치환된 페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 안트라세닐기, 치환 또는 비치환된 페난트레닐기, 치환 또는 비치환된 나프타세닐기, 치환 또는 비치환된 피레닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 p-터페닐기, 치환 또는 비치환된 m-터페닐기, 치환 또는 비치환된 o-터페닐기, 치환 또는 비치환된 크리세닐기, 치환 또는 비치환된 트리페닐렌기, 치환 또는 비치환된 페릴레닐기, 치환 또는 비치환된 플루오레닐기, 치환 또는 비치환된 인데닐기, 또는 이들의 조합일 수 있으나, 이에 제한되지는 않는다.More specifically, the substituted or unsubstituted C6 to C30 aryl group is a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthracenyl group, a substituted or unsubstituted phenanthrenyl group, a substituted or unsubstituted naphthyl group, or a substituted or unsubstituted phenanthrenyl group. An unsubstituted naphthacenyl group, a substituted or unsubstituted pyrenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted p-terphenyl group, a substituted or unsubstituted m-terphenyl group, a substituted or unsubstituted o- A terphenyl group, a substituted or unsubstituted chrysenyl group, a substituted or unsubstituted triphenylene group, a substituted or unsubstituted perylenyl group, a substituted or unsubstituted fluorenyl group, a substituted or unsubstituted indenyl group, or any of these It may be a combination, but is not limited thereto.
보다 구체적으로, 치환 또는 비치환된 C2 내지 C30 헤테로고리기는, 치환 또는 비치환된 퓨라닐기, 치환 또는 비치환된 티오페닐기, 치환 또는 비치환된 피롤릴기, 치환 또는 비치환된 피라졸릴기, 치환 또는 비치환된 이미다졸일기, 치환 또는 비치환된 트리아졸일기, 치환 또는 비치환된 옥사졸일기, 치환 또는 비치환된 티아졸일기, 치환 또는 비치환된 옥사디아졸일기, 치환 또는 비치환된 티아디아졸일기, 치환 또는 비치환된 피리딜기, 치환 또는 비치환된 피리미디닐기, 치환 또는 비치환된 피라지닐기, 치환 또는 비치환된 트리아지닐기, 치환 또는 비치환된 벤조퓨라닐기, 치환 또는 비치환된 벤조티오페닐기, 치환 또는 비치환된 벤즈이미다졸일기, 치환 또는 비치환된 인돌일기, 치환 또는 비치환된 퀴놀리닐기, 치환 또는 비치환된 이소퀴놀리닐기, 치환 또는 비치환된 퀴나졸리닐기, 치환 또는 비치환된 퀴녹살리닐기, 치환 또는 비치환된 나프티리디닐기, 치환 또는 비치환된 벤즈옥사진일기, 치환 또는 비치환된 벤조티아진일기, 치환 또는 비치환된 아크리디닐기, 치환 또는 비치환된 페나진일기, 치환 또는 비치환된 페노티아진일기, 치환 또는 비치환된 페녹사진일기, 치환 또는 비치환된 카바졸일기, 치환 또는 비치환된 디벤조퓨란일기, 또는 치환 또는 비치환된 디벤조티오펜일기, 또는 이들의 조합일 수 있으나, 이에 제한되지는 않는다.More specifically, the substituted or unsubstituted C2 to C30 heterocyclic group is a substituted or unsubstituted furanyl group, a substituted or unsubstituted thiophenyl group, a substituted or unsubstituted pyrrolyl group, a substituted or unsubstituted pyrazolyl group, or a substituted or unsubstituted pyrazolyl group. Or an unsubstituted imidazolyl group, a substituted or unsubstituted triazolyl group, a substituted or unsubstituted oxazolyl group, a substituted or unsubstituted thiazolyl group, a substituted or unsubstituted oxadiazolyl group, a substituted or unsubstituted Thiadiazolyl group, substituted or unsubstituted pyridyl group, substituted or unsubstituted pyrimidinyl group, substituted or unsubstituted pyrazinyl group, substituted or unsubstituted triazinyl group, substituted or unsubstituted benzofuranyl group, substituted Or an unsubstituted benzothiophenyl group, a substituted or unsubstituted benzimidazolyl group, a substituted or unsubstituted indolyl group, a substituted or unsubstituted quinolinyl group, a substituted or unsubstituted isoquinolinyl group, a substituted or unsubstituted Quinazolinyl group, substituted or unsubstituted quinoxalinyl group, substituted or unsubstituted naphthyridinyl group, substituted or unsubstituted benzoxazinyl group, substituted or unsubstituted benzothiazinyl group, substituted or unsubstituted acridinyl group , A substituted or unsubstituted phenazinyl group, a substituted or unsubstituted phenothiazinyl group, a substituted or unsubstituted phenoxazinyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted dibenzofuranyl group, or a substituted Or an unsubstituted dibenzothiophenyl group, or a combination thereof, but is not limited thereto.
본 명세서에서, “비치환”이란 수소 원자가 다른 치환기로 치환되지 않고 수소 원자로 남아있는 것을 의미한다.In this specification, “unsubstituted” means that a hydrogen atom remains as a hydrogen atom without being substituted with another substituent.
본 명세서에서, "수소 치환 (-H)"은 "중수소 치환 (-D)" 또는 "삼중수소 치환 (-T)"을 포함할 수 있다.In this specification, "hydrogen substitution (-H)" may include "deuterium substitution (-D)" or "tritium substitution (-T)".
본 명세서에서, 정공 특성이란, 전기장(electric field)을 가했을 때 전자를 공여하여 정공을 형성할 수 있는 특성을 말하는 것으로, HOMO 준위를 따라 전도 특성을 가져 양극에서 형성된 정공의 발광층으로의 주입, 발광층에서 형성된 정공의 양극으로의 이동 및 발광층에서의 이동을 용이하게 하는 특성을 의미한다. In the present specification, the hole characteristic refers to a characteristic that can form holes by donating electrons when an electric field is applied, and has conduction characteristics along the HOMO level, so that holes formed at the anode are injected into the light emitting layer, the light emitting layer It means a property that facilitates the movement of holes formed in the anode to the anode and in the light emitting layer.
또한 전자 특성이란, 전기장을 가했을 때 전자를 받을 수 있는 특성을 말하는 것으로, LUMO 준위를 따라 전도 특성을 가져 음극에서 형성된 전자의 발광층으로의 주입, 발광층에서 형성된 전자의 음극으로의 이동 및 발광층에서의 이동을 용이하게 하는 특성을 의미한다. In addition, electronic properties refer to the characteristics of receiving electrons when an electric field is applied, and has conductivity along the LUMO level, so that electrons formed in the cathode are injected into the light emitting layer, electrons formed in the light emitting layer move to the cathode, and in the light emitting layer A property that facilitates movement.
이하 일 구현예에 따른 유기 광전자 소자용 조성물을 설명한다.Hereinafter, a composition for an organic optoelectronic device according to an embodiment will be described.
일 구현예에 따른 유기 광전자 소자용 조성물은 제1 화합물, 및 제2 화합물을 포함한다.A composition for an organic optoelectronic device according to an embodiment includes a first compound and a second compound.
상기 제1 화합물은 하기 화학식 1로 표시된다.The first compound is represented by Formula 1 below.
[화학식 1][Formula 1]
Figure PCTKR2023002090-appb-img-000003
Figure PCTKR2023002090-appb-img-000003
상기 화학식 1에서,In Formula 1,
Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,Ar 1 and Ar 2 are each independently a substituted or unsubstituted C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group;
L1 내지 L3은 각각 독립적으로 단일 결합, 치환 또는 비치환된 C6 내지 C30 아릴렌기 또는 치환 또는 비치환된 C2 내지 C30 헤테로아릴렌기이며,L 1 to L 3 are each independently a single bond, a substituted or unsubstituted C6 to C30 arylene group or a substituted or unsubstituted C2 to C30 heteroarylene group,
R1 내지 R4는 각각 독립적으로 수소, 중수소, 시아노기, 할로겐기, 치환 또는 비치환된 아민기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,R 1 to R 4 are each independently hydrogen, heavy hydrogen, a cyano group, a halogen group, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or An unsubstituted C2 to C30 heterocyclic group,
n1은 1 내지 3의 정수 중 하나이고,n1 is an integer from 1 to 3;
n2 및 n3은 각각 독립적으로 1 또는 2의 정수 중 하나이며,n2 and n3 are each independently an integer of 1 or 2,
n4는 1 내지 4의 정수 중 하나이다.n4 is an integer from 1 to 4;
화학식 1로 표시되는 제1 화합물은 크라이센에 아민이 치환된 구조로서 길게 융합된 크라이센 고리가 아민을 정공과 에너지에 대해 안정하게 도움을 주어 장수명의 소자 구현에 유리하고, 특히 강건한 융합 아릴렌인 크라이센은 열적으로도 매우 안정하다.The first compound represented by Formula 1 is a structure in which amine is substituted for chrysene, and the long fused chrysene ring helps to stabilize the amine for holes and energy, which is advantageous for realizing a long-life device, and is particularly robust fused arylene Phosphorus Krysen is also very thermally stable.
일 예로 상기 화학식 1은 하기 화학식 1-1 내지 화학식 1-4 중 어느 하나로 표시될 수 있다.For example, Chemical Formula 1 may be represented by any one of Chemical Formulas 1-1 to 1-4.
[화학식 1-1] [화학식 1-2][Formula 1-1] [Formula 1-2]
Figure PCTKR2023002090-appb-img-000004
Figure PCTKR2023002090-appb-img-000004
[화학식 1-3] [화학식 1-4][Formula 1-3] [Formula 1-4]
Figure PCTKR2023002090-appb-img-000005
Figure PCTKR2023002090-appb-img-000005
상기 화학식 1-1 내지 화학식 1-4에서,In Formula 1-1 to Formula 1-4,
Ar1, Ar2, L1 내지 L3, R1 내지 R4, 및 n1 내지 n4의 정의는 전술한 바와 같다.Ar 1 , Ar 2 , L 1 to L 3 , R 1 to R 4 , and n1 to n4 are defined as described above.
구체적인 일 예로 상기 화학식 1은 상기 화학식 1-2로 표시될 수 있다.As a specific example, Chemical Formula 1 may be represented by Chemical Formula 1-2.
상기 화학식 1의 Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 터페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 안트라세닐기, 치환 또는 비치환된 페난트레닐기, 치환 또는 비치환된 트리페닐렌기, 치환 또는 비치환된 디벤조퓨란일기, 치환 또는 비치환된 디벤조티오페일기, 치환 또는 비치환된 벤조나프토퓨란일기 또는 치환 또는 비치환된 벤조나프토티오펜일기일 수 있다.Ar 1 and Ar 2 in Formula 1 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted terphenyl group, a substituted or unsubstituted naphthyl group, or a substituted or unsubstituted anthrayl group. Cenyl group, substituted or unsubstituted phenanthrenyl group, substituted or unsubstituted triphenylene group, substituted or unsubstituted dibenzofuranyl group, substituted or unsubstituted dibenzothiophenyl group, substituted or unsubstituted benzonaphtho It may be a furanyl group or a substituted or unsubstituted benzonaphthothiophenyl group.
일 예로 Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 디벤조퓨란일기, 치환 또는 비치환된 디벤조티오페일기, 치환 또는 비치환된 벤조나프토퓨란일기 또는 치환 또는 비치환된 벤조나프토티오펜일기일 수 있다.For example, Ar 1 and Ar 2 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted dibenzofuranyl group, or a substituted or unsubstituted dibenzofuranyl group. It may be a benzothiophenyl group, a substituted or unsubstituted benzonaphthofuranyl group, or a substituted or unsubstituted benzonaphthothiophenyl group.
일 예로 상기 L1 내지 L3은 각각 독립적으로 단일 결합, 치환 또는 비치환된 페닐렌기, 또는 치환 또는 비치환된 나프틸렌기일 수 있다.For example, L 1 to L 3 may each independently be a single bond, a substituted or unsubstituted phenylene group, or a substituted or unsubstituted naphthylene group.
예컨대 상기 화학식 1의 L1은 단일 결합이고,For example, L 1 in Formula 1 is a single bond,
*-L2-Ar1 및 *-L3-Ar2는 각각 독립적으로 하기 그룹 Ⅰ에 나열된 치환기 중에서 선택될 수 있다.*-L 2 -Ar 1 and *-L 3 -Ar 2 may each independently be selected from substituents listed in Group I below.
[그룹 Ⅰ] [Group I]
Figure PCTKR2023002090-appb-img-000006
Figure PCTKR2023002090-appb-img-000006
상기 그룹 Ⅰ에서, 상기 치환기는 비치환된 형태이거나 추가 치환기로 치환된 형태일 수 있으며, *은 연결 지점이다.In Group I, the substituent may be unsubstituted or substituted with an additional substituent, and * is a linking point.
상기 추가 치환기는 중수소, C1 내지 C5 알킬기, 또는 C6 내지 C18 아릴기일 수 있다.The additional substituent may be deuterium, a C1 to C5 alkyl group, or a C6 to C18 aryl group.
가장 구체적인 일 실시예에서 상기 화학식 1로 표시되는 제1 화합물은 하기 그룹 1에 나열된 화합물에서 선택되는 하나일 수 있으나, 이에 한정되는 것은 아니다.In a most specific embodiment, the first compound represented by Formula 1 may be one selected from compounds listed in Group 1 below, but is not limited thereto.
[그룹 1] [Group 1]
[A-1] [A-2] [A-3] [A-4][A-1] [A-2] [A-3] [A-4]
Figure PCTKR2023002090-appb-img-000007
Figure PCTKR2023002090-appb-img-000007
[A-5] [A-6] [A-7] [A-8][A-5] [A-6] [A-7] [A-8]
Figure PCTKR2023002090-appb-img-000008
Figure PCTKR2023002090-appb-img-000008
[A-9] [A-10] [A-11] [A-12][A-9] [A-10] [A-11] [A-12]
Figure PCTKR2023002090-appb-img-000009
Figure PCTKR2023002090-appb-img-000009
[A-13] [A-14] [A-15] [A-16][A-13] [A-14] [A-15] [A-16]
Figure PCTKR2023002090-appb-img-000010
Figure PCTKR2023002090-appb-img-000010
[A-17] [A-18] [A-19] [A-20][A-17] [A-18] [A-19] [A-20]
Figure PCTKR2023002090-appb-img-000011
Figure PCTKR2023002090-appb-img-000011
[A-21] [A-22] [A-23] [A-24][A-21] [A-22] [A-23] [A-24]
Figure PCTKR2023002090-appb-img-000012
Figure PCTKR2023002090-appb-img-000012
[A-25] [A-26] [A-27] [A-28][A-25] [A-26] [A-27] [A-28]
Figure PCTKR2023002090-appb-img-000013
Figure PCTKR2023002090-appb-img-000013
[A-29] [A-30] [A-31] [A-32][A-29] [A-30] [A-31] [A-32]
Figure PCTKR2023002090-appb-img-000014
Figure PCTKR2023002090-appb-img-000014
[A-33] [A-34] [A-35] [A-36][A-33] [A-34] [A-35] [A-36]
Figure PCTKR2023002090-appb-img-000015
Figure PCTKR2023002090-appb-img-000015
[A-37] [A-38] [A-39] [A-40][A-37] [A-38] [A-39] [A-40]
Figure PCTKR2023002090-appb-img-000016
Figure PCTKR2023002090-appb-img-000016
[A-41] [A-42] [A-43] [A-44][A-41] [A-42] [A-43] [A-44]
Figure PCTKR2023002090-appb-img-000017
Figure PCTKR2023002090-appb-img-000017
[A-45] [A-46] [A-47] [A-48][A-45] [A-46] [A-47] [A-48]
Figure PCTKR2023002090-appb-img-000018
Figure PCTKR2023002090-appb-img-000018
[A-49] [A-50] [A-51] [A-52][A-49] [A-50] [A-51] [A-52]
Figure PCTKR2023002090-appb-img-000019
Figure PCTKR2023002090-appb-img-000019
[A-53] [A-54] [A-55] [A-56][A-53] [A-54] [A-55] [A-56]
Figure PCTKR2023002090-appb-img-000020
Figure PCTKR2023002090-appb-img-000020
[A-57] [A-58] [A-59] [A-60][A-57] [A-58] [A-59] [A-60]
Figure PCTKR2023002090-appb-img-000021
Figure PCTKR2023002090-appb-img-000021
[A-61] [A-62] [A-63] [A-64][A-61] [A-62] [A-63] [A-64]
Figure PCTKR2023002090-appb-img-000022
Figure PCTKR2023002090-appb-img-000022
[A-65] [A-66] [A-67] [A-68][A-65] [A-66] [A-67] [A-68]
Figure PCTKR2023002090-appb-img-000023
Figure PCTKR2023002090-appb-img-000023
[A-69] [A-70] [A-71] [A-72][A-69] [A-70] [A-71] [A-72]
Figure PCTKR2023002090-appb-img-000024
Figure PCTKR2023002090-appb-img-000024
[A-73] [A-74] [A-75] [A-76][A-73] [A-74] [A-75] [A-76]
Figure PCTKR2023002090-appb-img-000025
Figure PCTKR2023002090-appb-img-000025
[A-77] [A-78] [A-79] [A-80][A-77] [A-78] [A-79] [A-80]
Figure PCTKR2023002090-appb-img-000026
Figure PCTKR2023002090-appb-img-000026
[A-81] [A-82] [A-83] [A-84][A-81] [A-82] [A-83] [A-84]
Figure PCTKR2023002090-appb-img-000027
Figure PCTKR2023002090-appb-img-000027
[A-85] [A-86] [A-87] [A-88][A-85] [A-86] [A-87] [A-88]
Figure PCTKR2023002090-appb-img-000028
Figure PCTKR2023002090-appb-img-000028
[A-89] [A-90] [A-91] [A-92][A-89] [A-90] [A-91] [A-92]
Figure PCTKR2023002090-appb-img-000029
Figure PCTKR2023002090-appb-img-000029
[A-93] [A-94] [A-95] [A-96][A-93] [A-94] [A-95] [A-96]
Figure PCTKR2023002090-appb-img-000030
Figure PCTKR2023002090-appb-img-000030
[A-97] [A-98] [A-99] [A-100][A-97] [A-98] [A-99] [A-100]
Figure PCTKR2023002090-appb-img-000031
Figure PCTKR2023002090-appb-img-000031
[A-101] [A-102] [A-103] [A-104][A-101] [A-102] [A-103] [A-104]
Figure PCTKR2023002090-appb-img-000032
Figure PCTKR2023002090-appb-img-000032
[A-105] [A-106] [A-107] [A-108][A-105] [A-106] [A-107] [A-108]
Figure PCTKR2023002090-appb-img-000033
Figure PCTKR2023002090-appb-img-000033
[A-109] [A-110] [A-111] [A-112][A-109] [A-110] [A-111] [A-112]
Figure PCTKR2023002090-appb-img-000034
Figure PCTKR2023002090-appb-img-000034
[A-113] [A-114] [A-115] [A-116][A-113] [A-114] [A-115] [A-116]
Figure PCTKR2023002090-appb-img-000035
Figure PCTKR2023002090-appb-img-000035
[A-117] [A-118] [A-119] [A-120][A-117] [A-118] [A-119] [A-120]
Figure PCTKR2023002090-appb-img-000036
Figure PCTKR2023002090-appb-img-000036
[A-121] [A-122] [A-123] [A-124][A-121] [A-122] [A-123] [A-124]
Figure PCTKR2023002090-appb-img-000037
Figure PCTKR2023002090-appb-img-000037
[A-125] [A-126] [A-127] [A-128][A-125] [A-126] [A-127] [A-128]
Figure PCTKR2023002090-appb-img-000038
Figure PCTKR2023002090-appb-img-000038
[A-129] [A-130] [A-131] [A-132][A-129] [A-130] [A-131] [A-132]
Figure PCTKR2023002090-appb-img-000039
Figure PCTKR2023002090-appb-img-000039
[A-133] [A-134] [A-135] [A-136][A-133] [A-134] [A-135] [A-136]
Figure PCTKR2023002090-appb-img-000040
Figure PCTKR2023002090-appb-img-000040
[A-137] [A-138] [A-139] [A-140][A-137] [A-138] [A-139] [A-140]
Figure PCTKR2023002090-appb-img-000041
Figure PCTKR2023002090-appb-img-000041
[A-141] [A-142] [A-143] [A-144][A-141] [A-142] [A-143] [A-144]
Figure PCTKR2023002090-appb-img-000042
Figure PCTKR2023002090-appb-img-000042
[A-145] [A-146] [A-147] [A-148][A-145] [A-146] [A-147] [A-148]
Figure PCTKR2023002090-appb-img-000043
Figure PCTKR2023002090-appb-img-000043
[A-149] [A-150] [A-151] [A-152][A-149] [A-150] [A-151] [A-152]
Figure PCTKR2023002090-appb-img-000044
Figure PCTKR2023002090-appb-img-000044
[A-153] [A-154] [A-155] [A-156][A-153] [A-154] [A-155] [A-156]
Figure PCTKR2023002090-appb-img-000045
Figure PCTKR2023002090-appb-img-000045
[A-157] [A-158] [A-159] [A-160][A-157] [A-158] [A-159] [A-160]
Figure PCTKR2023002090-appb-img-000046
Figure PCTKR2023002090-appb-img-000046
[A-161] [A-162] [A-163] [A-164][A-161] [A-162] [A-163] [A-164]
Figure PCTKR2023002090-appb-img-000047
Figure PCTKR2023002090-appb-img-000047
[A-165] [A-166] [A-167] [A-168][A-165] [A-166] [A-167] [A-168]
Figure PCTKR2023002090-appb-img-000048
Figure PCTKR2023002090-appb-img-000048
상기 제2 화합물은 하기 화학식 2로 표시된다.The second compound is represented by Formula 2 below.
[화학식 2][Formula 2]
Figure PCTKR2023002090-appb-img-000049
Figure PCTKR2023002090-appb-img-000049
상기 화학식 2에서,In Formula 2,
Ar3 및 Ar4는 각각 독립적으로 치환 또는 비치환된 C6 내지 C20 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,Ar 3 and Ar 4 are each independently a substituted or unsubstituted C6 to C20 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group;
L4 내지 L6은 각각 독립적으로 단일결합 또는 치환 또는 비치환된 C6 내지 C30 아릴렌기이고, L 4 to L 6 are each independently a single bond or a substituted or unsubstituted C6 to C30 arylene group;
R5 내지 R9는 각각 독립적으로 수소, 중수소, 시아노기, 할로겐기, 치환 또는 비치환된 아민기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,R 5 to R 9 are each independently hydrogen, heavy hydrogen, a cyano group, a halogen group, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or An unsubstituted C2 to C30 heterocyclic group,
m1 내지 m3 은 각각 독립적으로 0 또는 1의 정수이고,m1 to m3 are each independently an integer of 0 or 1,
0 ≤ m1+m2+m3 ≤ 1이며,0 ≤ m1+m2+m3 ≤ 1, and
n5 내지 n9는 각각 독립적으로 1 내지 4의 정수 중 하나이다.n5 to n9 are each independently an integer of 1 to 4;
상기 제2 화합물은 상기 제1 화합물과 함께 발광층에 사용되어 전하의 이동성을 높이고 안정성을 높임으로써 발광 효율 및 수명 특성을 개선시킬 수 있다.The second compound may be used together with the first compound in the light emitting layer to increase charge mobility and stability, thereby improving light emitting efficiency and lifetime characteristics.
일 예로 상기 화학식 2는 하기 화학식 2A 내지 화학식 2D 중 어느 하나로 표시될 수 있다.For example, Chemical Formula 2 may be represented by any one of Chemical Formulas 2A to 2D.
[화학식 2A] [화학식 2B][Formula 2A] [Formula 2B]
Figure PCTKR2023002090-appb-img-000050
Figure PCTKR2023002090-appb-img-000050
[화학식 2C] [화학식 2D][Formula 2C] [Formula 2D]
Figure PCTKR2023002090-appb-img-000051
Figure PCTKR2023002090-appb-img-000051
상기 화학식 2A 내지 화학식 2D 에서,In Formulas 2A to 2D,
Ar3, Ar4, L4 내지 L6, R6 내지 R9, 및 n6 내지 n9의 정의는 전술한 바와 같고,Ar 3 , Ar 4 , L 4 to L 6 , R 6 to R 9 , and n6 to n9 are defined as described above,
R5a 및 R5b는 각각 독립적으로 각각 독립적으로 수소, 중수소, 시아노기, 할로겐기, 치환 또는 비치환된 아민기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이다.R 5a and R 5b are each independently selected from hydrogen, heavy hydrogen, a cyano group, a halogen group, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, or a substituted or unsubstituted C6 to C30 aryl group. Or a substituted or unsubstituted C2 to C30 heterocyclic group.
일 예로, 상기 화학식 2의 Ar3 및 Ar4는 각각 독립적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 터페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 안트라세닐기, 치환 또는 비치환된 페난트레닐기, 치환 또는 비치환된 트리페닐렌기, 치환 또는 비치환된 디벤조퓨란일기, 치환 또는 비치환된 디벤조티오펜일기, 치환 또는 비치환된 치환 또는 비치환된 벤조나프토퓨란일기 또는 치환 또는 비치환된 벤조나프토티오펜일기일 수 있다. For example, Ar 3 and Ar 4 in Formula 2 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted terphenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted biphenyl group, or a substituted or unsubstituted naphthyl group. substituted anthracenyl group, substituted or unsubstituted phenanthrenyl group, substituted or unsubstituted triphenylene group, substituted or unsubstituted dibenzofuranyl group, substituted or unsubstituted dibenzothiophenyl group, substituted or unsubstituted It may be a substituted or unsubstituted benzonaphthofuranyl group or a substituted or unsubstituted benzonaphthothiophenyl group.
구체적인 일 예로 상기 Ar3 및 Ar4는 각각 독립적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 디벤조퓨란일기, 치환 또는 비치환된 디벤조티오페일기, 치환 또는 비치환된 벤조나프토퓨란일기 또는 치환 또는 비치환된 벤조나프토티오펜일기일 수 있다.As a specific example, Ar 3 and Ar 4 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted dibenzofuranyl group, a substituted or unsubstituted dibenzofuranyl group, or a substituted or unsubstituted biphenyl group. may be a substituted or unsubstituted dibenzothiophenyl group, a substituted or unsubstituted benzonaphthofuranyl group, or a substituted or unsubstituted benzonaphthothiophenyl group.
일 예로 상기 화학식 2의 L4 내지 L6은 각각 독립적으로 단일 결합, 치환 또는 비치환된 페닐렌기, 또는 치환 또는 비치환된 나프틸렌기일 수 있다. For example, L 4 to L 6 in Formula 2 may each independently be a single bond, a substituted or unsubstituted phenylene group, or a substituted or unsubstituted naphthylene group.
예컨대 상기 화학식 2의 L4는 단일 결합이고,For example, L 4 in Formula 2 is a single bond;
*-L5-Ar3 및 *-L6-Ar4는 각각 독립적으로 하기 그룹 Ⅱ에 나열된 치환기 중에서 선택될 수 있다.*-L 5 -Ar 3 and *-L 6 -Ar 4 may each independently be selected from substituents listed in Group II below.
[그룹 Ⅱ] [Group II]
Figure PCTKR2023002090-appb-img-000052
Figure PCTKR2023002090-appb-img-000052
상기 그룹 Ⅱ에서, 상기 치환기는 비치환된 형태이거나 추가 치환기로 치환된 형태일 수 있으며, *은 연결 지점이다.In Group II, the substituent may be unsubstituted or substituted with an additional substituent, and * is a linking point.
상기 추가 치환기는 중수소, C1 내지 C5 알킬기, 또는 C6 내지 C18 아릴기일 수 있다.The additional substituent may be deuterium, a C1 to C5 alkyl group, or a C6 to C18 aryl group.
예컨대 제2 화합물은 하기 그룹 2에 나열된 화합물에서 선택된 하나일 수 있으나, 이에 한정되는 것은 아니다.For example, the second compound may be one selected from compounds listed in Group 2 below, but is not limited thereto.
[그룹 2] [Group 2]
[B-1] [B-2] [B-3] [B-4][B-1] [B-2] [B-3] [B-4]
Figure PCTKR2023002090-appb-img-000053
Figure PCTKR2023002090-appb-img-000053
[B-5] [B-6] [B-7] [B-8][B-5] [B-6] [B-7] [B-8]
Figure PCTKR2023002090-appb-img-000054
Figure PCTKR2023002090-appb-img-000054
[B-9] [B-10] [B-11] [B-12][B-9] [B-10] [B-11] [B-12]
Figure PCTKR2023002090-appb-img-000055
Figure PCTKR2023002090-appb-img-000055
[B-13] [B-14] [B-15] [B-16][B-13] [B-14] [B-15] [B-16]
Figure PCTKR2023002090-appb-img-000056
Figure PCTKR2023002090-appb-img-000056
[B-17] [B-18] [B-19] [B-20][B-17] [B-18] [B-19] [B-20]
Figure PCTKR2023002090-appb-img-000057
Figure PCTKR2023002090-appb-img-000057
[B-21] [B-22] [B-23] [B-24][B-21] [B-22] [B-23] [B-24]
Figure PCTKR2023002090-appb-img-000058
Figure PCTKR2023002090-appb-img-000058
[B-25] [B-26] [B-27] [B-28][B-25] [B-26] [B-27] [B-28]
Figure PCTKR2023002090-appb-img-000059
Figure PCTKR2023002090-appb-img-000059
[B-29] [B-30] [B-31] [B-32][B-29] [B-30] [B-31] [B-32]
Figure PCTKR2023002090-appb-img-000060
Figure PCTKR2023002090-appb-img-000060
[B-33] [B-34] [B-35] [B-36][B-33] [B-34] [B-35] [B-36]
Figure PCTKR2023002090-appb-img-000061
Figure PCTKR2023002090-appb-img-000061
[B-37] [B-38] [B-39] [B-40][B-37] [B-38] [B-39] [B-40]
Figure PCTKR2023002090-appb-img-000062
Figure PCTKR2023002090-appb-img-000062
[B-41] [B-42] [B-43] [B-44][B-41] [B-42] [B-43] [B-44]
Figure PCTKR2023002090-appb-img-000063
Figure PCTKR2023002090-appb-img-000063
[B-45] [B-46] [B-47] [B-48][B-45] [B-46] [B-47] [B-48]
Figure PCTKR2023002090-appb-img-000064
Figure PCTKR2023002090-appb-img-000064
[B-49] [B-50] [B-51] [B-52][B-49] [B-50] [B-51] [B-52]
Figure PCTKR2023002090-appb-img-000065
Figure PCTKR2023002090-appb-img-000065
[B-53] [B-54] [B-55] [B-56] [B-53] [B-54] [B-55] [B-56]
Figure PCTKR2023002090-appb-img-000066
Figure PCTKR2023002090-appb-img-000066
[B-57] [B-58] [B-59] [B-60][B-57] [B-58] [B-59] [B-60]
Figure PCTKR2023002090-appb-img-000067
Figure PCTKR2023002090-appb-img-000067
[B-61] [B-62] [B-63] [B-64][B-61] [B-62] [B-63] [B-64]
Figure PCTKR2023002090-appb-img-000068
Figure PCTKR2023002090-appb-img-000068
[B-65] [B-66] [B-67] [B-68][B-65] [B-66] [B-67] [B-68]
Figure PCTKR2023002090-appb-img-000069
Figure PCTKR2023002090-appb-img-000069
[B-69] [B-70] [B-71] [B-72][B-69] [B-70] [B-71] [B-72]
Figure PCTKR2023002090-appb-img-000070
Figure PCTKR2023002090-appb-img-000070
[B-73] [B-74] [B-75] [B-76][B-73] [B-74] [B-75] [B-76]
Figure PCTKR2023002090-appb-img-000071
Figure PCTKR2023002090-appb-img-000071
[B-77] [B-78] [B-79] [B-80][B-77] [B-78] [B-79] [B-80]
Figure PCTKR2023002090-appb-img-000072
Figure PCTKR2023002090-appb-img-000072
[B-81] [B-82] [B-83] [B-84][B-81] [B-82] [B-83] [B-84]
Figure PCTKR2023002090-appb-img-000073
Figure PCTKR2023002090-appb-img-000073
[B-85] [B-86] [B-87] [B-88][B-85] [B-86] [B-87] [B-88]
Figure PCTKR2023002090-appb-img-000074
Figure PCTKR2023002090-appb-img-000074
[B-89] [B-90] [B-91] [B-92][B-89] [B-90] [B-91] [B-92]
Figure PCTKR2023002090-appb-img-000075
Figure PCTKR2023002090-appb-img-000075
[B-93] [B-94] [B-95] [B-96][B-93] [B-94] [B-95] [B-96]
Figure PCTKR2023002090-appb-img-000076
Figure PCTKR2023002090-appb-img-000076
[B-97] [B-98] [B-99] [B-100][B-97] [B-98] [B-99] [B-100]
Figure PCTKR2023002090-appb-img-000077
Figure PCTKR2023002090-appb-img-000077
[B-101] [B-102] [B-103] [B-104][B-101] [B-102] [B-103] [B-104]
Figure PCTKR2023002090-appb-img-000078
Figure PCTKR2023002090-appb-img-000078
[B-105] [B-106] [B-107] [B-108][B-105] [B-106] [B-107] [B-108]
Figure PCTKR2023002090-appb-img-000079
Figure PCTKR2023002090-appb-img-000079
[B-109] [B-110] [B-111] [B-112][B-109] [B-110] [B-111] [B-112]
Figure PCTKR2023002090-appb-img-000080
Figure PCTKR2023002090-appb-img-000080
[B-113] [B-114] [B-115] [B-116][B-113] [B-114] [B-115] [B-116]
Figure PCTKR2023002090-appb-img-000081
Figure PCTKR2023002090-appb-img-000081
[B-117] [B-118] [B-119] [B-120][B-117] [B-118] [B-119] [B-120]
Figure PCTKR2023002090-appb-img-000082
Figure PCTKR2023002090-appb-img-000082
[B-121] [B-122] [B-123] [B-124][B-121] [B-122] [B-123] [B-124]
Figure PCTKR2023002090-appb-img-000083
Figure PCTKR2023002090-appb-img-000083
[B-125] [B-126] [B-127] [B-128][B-125] [B-126] [B-127] [B-128]
Figure PCTKR2023002090-appb-img-000084
Figure PCTKR2023002090-appb-img-000084
[B-129] [B-130] [B-131] [B-132][B-129] [B-130] [B-131] [B-132]
Figure PCTKR2023002090-appb-img-000085
Figure PCTKR2023002090-appb-img-000085
[B-133] [B-134] [B-135] [B-136][B-133] [B-134] [B-135] [B-136]
Figure PCTKR2023002090-appb-img-000086
Figure PCTKR2023002090-appb-img-000086
[B-137] [B-138] [B-139] [B-140][B-137] [B-138] [B-139] [B-140]
Figure PCTKR2023002090-appb-img-000087
Figure PCTKR2023002090-appb-img-000087
[B-141] [B-142] [B-143] [B-144][B-141] [B-142] [B-143] [B-144]
Figure PCTKR2023002090-appb-img-000088
Figure PCTKR2023002090-appb-img-000088
[B-145] [B-146] [B-147] [B-148][B-145] [B-146] [B-147] [B-148]
Figure PCTKR2023002090-appb-img-000089
Figure PCTKR2023002090-appb-img-000089
[B-149] [B-150] [B-151] [B-152][B-149] [B-150] [B-151] [B-152]
Figure PCTKR2023002090-appb-img-000090
Figure PCTKR2023002090-appb-img-000090
[B-153] [B-154] [B-155] [B-156][B-153] [B-154] [B-155] [B-156]
Figure PCTKR2023002090-appb-img-000091
Figure PCTKR2023002090-appb-img-000091
[B-157] [B-158] [B-159] [B-160][B-157] [B-158] [B-159] [B-160]
Figure PCTKR2023002090-appb-img-000092
Figure PCTKR2023002090-appb-img-000092
[B-161] [B-162] [B-163] [B-164][B-161] [B-162] [B-163] [B-164]
Figure PCTKR2023002090-appb-img-000093
Figure PCTKR2023002090-appb-img-000093
[B-165] [B-166] [B-167] [B-168][B-165] [B-166] [B-167] [B-168]
Figure PCTKR2023002090-appb-img-000094
Figure PCTKR2023002090-appb-img-000094
[B-169] [B-170] [B-171] [B-172][B-169] [B-170] [B-171] [B-172]
Figure PCTKR2023002090-appb-img-000095
Figure PCTKR2023002090-appb-img-000095
[B-173] [B-174] [B-175] [B-176][B-173] [B-174] [B-175] [B-176]
Figure PCTKR2023002090-appb-img-000096
Figure PCTKR2023002090-appb-img-000096
[B-177] [B-178] [B-179] [B-180][B-177] [B-178] [B-179] [B-180]
Figure PCTKR2023002090-appb-img-000097
Figure PCTKR2023002090-appb-img-000097
[B-181] [B-182] [B-183] [B-184][B-181] [B-182] [B-183] [B-184]
Figure PCTKR2023002090-appb-img-000098
Figure PCTKR2023002090-appb-img-000098
[B-185] [B-186] [B-187] [B-188][B-185] [B-186] [B-187] [B-188]
Figure PCTKR2023002090-appb-img-000099
Figure PCTKR2023002090-appb-img-000099
[B-189] [B-190] [B-191] [B-192][B-189] [B-190] [B-191] [B-192]
Figure PCTKR2023002090-appb-img-000100
Figure PCTKR2023002090-appb-img-000100
[B-193] [B-194] [B-195] [B-196][B-193] [B-194] [B-195] [B-196]
Figure PCTKR2023002090-appb-img-000101
Figure PCTKR2023002090-appb-img-000101
[B-197] [B-198] [B-199] [B-200][B-197] [B-198] [B-199] [B-200]
Figure PCTKR2023002090-appb-img-000102
Figure PCTKR2023002090-appb-img-000102
[B-201] [B-202] [B-203] [B-204][B-201] [B-202] [B-203] [B-204]
Figure PCTKR2023002090-appb-img-000103
Figure PCTKR2023002090-appb-img-000103
[B-205] [B-206] [B-207] [B-208][B-205] [B-206] [B-207] [B-208]
Figure PCTKR2023002090-appb-img-000104
Figure PCTKR2023002090-appb-img-000104
구체적인 일 실시예에서, 상기 제1 화합물은 상기 화학식 1-2로 표시되고,In a specific embodiment, the first compound is represented by Formula 1-2,
상기 제2 화합물은 상기 화학식 2B 내지 화학식 2C 중 어느 하나로 표시될 수 있다.The second compound may be represented by any one of Chemical Formulas 2B to 2C.
제1 화합물과 제2 화합물은 예컨대 1:99 내지 99:1의 중량비로 포함될 수 있다. 상기 범위로 포함됨으로써 제1 화합물의 정공 수송 능력과 제2 화합물의 전자 수송 능력을 이용해 적절한 중량비를 맞추어 바이폴라 특성을 구현하여 효율과 수명을 개선할 수 있다. 상기 범위 내에서 예컨대 약 10:90 내지 90:10, 약 20:80 내지 80:20의 중량비로 포함될 수 있고, 예컨대 약 20:80 내지 약 70: 30, 약 20:80 내지 약 60:40, 그리고 약 20:80 내지 약 50:50의 중량비로 포함될 수 있다. 구체적인 일 예로, 20:80, 30:70, 또는 40:60의 중량비로 포함될 수 있다.The first compound and the second compound may be included in a weight ratio of, for example, 1:99 to 99:1. By being included within the above range, efficiency and lifespan can be improved by implementing bipolar characteristics by setting an appropriate weight ratio using the hole transport capability of the first compound and the electron transport capability of the second compound. Within the above range, for example, it may be included in a weight ratio of about 10:90 to 90:10, about 20:80 to 80:20, for example, about 20:80 to about 70:30, about 20:80 to about 60:40, And it may be included in a weight ratio of about 20:80 to about 50:50. As a specific example, it may be included in a weight ratio of 20:80, 30:70, or 40:60.
전술한 제1 화합물 및 제2 화합물 외에 1종 이상의 화합물을 더 포함할 수 있다. In addition to the first compound and the second compound described above, one or more compounds may be further included.
예컨대 전술한 유기 광전자 소자용 조성물은 도펀트를 더 포함할 수 있다.For example, the above-described composition for an organic optoelectronic device may further include a dopant.
도펀트는 예컨대 인광 도펀트일 수 있고, 예컨대 적색, 녹색 또는 청색의 인광 도펀트일 수 있고, 예컨대 적색 또는 녹색 인광 도펀트일 수 있다.The dopant may be, for example, a phosphorescent dopant, for example, a red, green or blue phosphorescent dopant, and may be, for example, a red or green phosphorescent dopant.
도펀트는 유기 광전자 소자용 조성물에 미량 혼합되어 발광을 일으키는 물질로, 일반적으로 삼중항 상태 이상으로 여기시키는 다중항 여기(multiple excitation)에 의해 발광하는 금속 착체(metal complex)와 같은 물질이 사용될 수 있다. 도펀트는 예컨대 무기, 유기, 유무기 화합물일 수 있으며, 1종 또는 2종 이상 포함될 수 있다.A dopant is a material that causes light emission by being mixed in a small amount in a composition for an organic optoelectronic device, and a material such as a metal complex that emits light by multiple excitation that is excited in a triplet state or higher may be used. . The dopant may be, for example, an inorganic, organic, or organic-inorganic compound, and may include one type or two or more types.
도펀트의 일 예로 인광 도펀트를 들 수 있으며, 인광 도펀트의 예로는 Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, Tm, Fe, Co, Ni, Ru, Rh, Pd 또는 이들의 조합을 포함하는 유기 금속화합물을 들 수 있다. 인광 도펀트는 예컨대 하기 화학식 Z로 표현되는 화합물을 사용할 수 있으나, 이에 한정되는 것은 아니다.An example of the dopant may include a phosphorescent dopant, and examples of the phosphorescent dopant include Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, Tm, Fe, Co, Ni, Ru, Rh, Pd, or a combination thereof. Organometallic compounds containing As the phosphorescent dopant, for example, a compound represented by Chemical Formula Z may be used, but is not limited thereto.
[화학식 Z][Formula Z]
L7MXL 7 MX
상기 화학식 Z에서, M은 금속이고, L7 및 X은 서로 같거나 다르며 M과 착화합물을 형성하는 리간드이다. In Formula Z, M is a metal, L 7 and X are the same as or different from each other and are ligands that form a complex with M.
상기 M은 예컨대 Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, Tm, Fe, Co, Ni, Ru, Rh, Pd 또는 이들의 조합일 수 있고, 상기 L7 및 X은 예컨대 바이덴테이트 리간드일 수 있다.M may be, for example, Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, Tm, Fe, Co, Ni, Ru, Rh, Pd, or a combination thereof, and L 7 and X may be, for example, biden It may be a tate ligand.
L7 및 X 로 표시되는 리간드의 예로는 하기 그룹 A에 나열된 화학식에서 선택될 수 있으나 이에 한정되는 것은 아니다.Examples of the ligand represented by L 7 and X may be selected from the formulas listed in Group A below, but are not limited thereto.
[그룹 A][Group A]
Figure PCTKR2023002090-appb-img-000105
Figure PCTKR2023002090-appb-img-000105
상기 그룹 A에서,In the group A,
R300 내지 R302는 각각 독립적으로, 수소, 중수소, 할로겐이 치환되거나 치환되지 않은 C1 내지 C30의 알킬기, C1 내지 C30의 알킬이 치환되거나 치환되지 않은 C6 내지 C30 아릴기 또는 할로겐이고,R 300 to R 302 are each independently hydrogen, deuterium, a C1 to C30 alkyl group with or without halogen substitution, a C6 to C30 aryl group with or without C1 to C30 alkyl substitution, or halogen;
R303 내지 R324는 각각 독립적으로, 수소, 중수소, 할로겐, 치환 또는 비치환된 C1 내지 C30의 알킬기, 치환 또는 비치환된 C1 내지 C30 알콕시기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C2 내지 C30의 알케닐기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C1 내지 C30 헤테로아릴기, 치환 또는 비치환된 C1 내지 C30 아미노기, 치환 또는 비치환된 C6 내지 C30 아릴아미노기, SF5, 치환 또는 비치환된 C1 내지 C30의 알킬기를 가지는 트리알킬실릴기, 치환 또는 비치환된 C1 내지 C30의 알킬기와 C6 내지 C30의 아릴기를 가지는 디알킬아릴실릴기, 또는 치환 또는 비치환된 C6 내지 C30의 아릴기를 가지는 트리아릴실릴기이다.R 303 to R 324 are each independently hydrogen, deuterium, halogen, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C1 to C30 alkoxy group, a substituted or unsubstituted C3 to C30 cycloalkyl group, or a substituted Or an unsubstituted C2 to C30 alkenyl group, a substituted or unsubstituted C6 to C30 aryl group, a substituted or unsubstituted C1 to C30 heteroaryl group, a substituted or unsubstituted C1 to C30 amino group, a substituted or unsubstituted C6 to C30 arylamino group, SF 5 , a trialkylsilyl group having a substituted or unsubstituted C1 to C30 alkyl group, a dialkylarylsilyl group having a substituted or unsubstituted C1 to C30 alkyl group and a C6 to C30 aryl group, or It is a triarylsilyl group having a substituted or unsubstituted C6 to C30 aryl group.
일 예로 하기 화학식 Ⅴ로 표시되는 도펀트를 포함할 수 있다.For example, a dopant represented by Chemical Formula V below may be included.
[화학식 Ⅴ] [Formula V]
Figure PCTKR2023002090-appb-img-000106
Figure PCTKR2023002090-appb-img-000106
상기 화학식 Ⅴ에서,In Formula V,
R101 내지 R116은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C10 알킬기, 치환 또는 비치환된 C6 내지 C20 아릴기, 또는 -SiR132R133R134이고,R 101 to R 116 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, a substituted or unsubstituted C6 to C20 aryl group, or -SiR 132 R 133 R 134 ;
상기 R132 내지 R134은 각각 독립적으로 C1 내지 C6 알킬기이고,Wherein R 132 to R 134 are each independently a C1 to C6 alkyl group;
R101 내지 R116 중 적어도 하나는 하기 화학식 Ⅴ-1로 표시되는 작용기이고,At least one of R 101 to R 116 is a functional group represented by Formula V-1 below;
L100은 1가 음이온의 두자리(bidentate) 리간드로, 탄소 또는 헤테로원자의 비공유 전자쌍을 통하여 이리듐에 배위결합하는 리간드이고,L 100 is a bidentate ligand of a monovalent anion, and is a ligand that coordinates with iridium through an unshared electron pair of a carbon or heteroatom,
n1 및 n2은 서로 독립적으로 0 내지 3의 정수 중 어느 하나이고, n1 + n2는 1 내지 3의 정수 중 어느 하나이고,n1 and n2 are independently any one of integers from 0 to 3, n1 + n2 is any one of integers from 1 to 3,
[화학식 Ⅴ-1][Formula V-1]
Figure PCTKR2023002090-appb-img-000107
Figure PCTKR2023002090-appb-img-000107
상기 화학식 Ⅴ-1에서,In Formula V-1,
R135 내지 R139은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C10 알킬기, 치환 또는 비치환된 C6 내지 C20 아릴기, 또는 -SiR132R133R134이고,R 135 to R 139 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, a substituted or unsubstituted C6 to C20 aryl group, or -SiR 132 R 133 R 134 ;
*는 탄소 원자와 연결되는 부분을 의미한다.* means a part connected to a carbon atom.
일 예로 하기 화학식 Z-1로 표시되는 도펀트를 포함할 수도 있다.For example, a dopant represented by Chemical Formula Z-1 may be included.
[화학식 Z-1][Formula Z-1]
Figure PCTKR2023002090-appb-img-000108
Figure PCTKR2023002090-appb-img-000108
상기 화학식 Z-1에서, 고리 A, B, C, 및 D는 각각 독립적으로 5원 또는 6원 카르보시클릭 또는 헤테로시클릭 고리를 나타내고;In the above formula Z-1, rings A, B, C, and D each independently represent a 5- or 6-membered carbocyclic or heterocyclic ring;
RA, RB, RC, 및 RD는 각각 독립적으로 일치환, 이치환, 삼치환, 또는 사치환, 또는 비치환을 나타내고;R A , R B , R C , and R D each independently represent mono-, di-, tri-, or tetra-substituted, or unsubstituted;
LB, LC, 및 LD은 각각 직접 결합, BR, NR, PR, O, S, Se, C=O, S=O, SO2, CRR', SiRR', GeRR', 및 이의 조합으로 이루어진 군에서 독립적으로 선택되고;L B , L C , and L D are each a direct bond, BR, NR, PR, O, S, Se, C=O, S=O, SO 2 , CRR', SiRR', GeRR', and combinations thereof independently selected from the group consisting of;
nA이 1인 경우, LE는 직접 결합, BR, NR, PR, O, S, Se, C=O, S=O, SO2, CRR', SiRR', GeRR', 및 이의 조합으로 이루어진 군에서 선택되고; nA이 0인 경우, LE는 존재하지 않고;When nA is 1, L E is a group consisting of a direct bond, BR, NR, PR, O, S, Se, C=O, S=O, SO 2 , CRR', SiRR', GeRR', and combinations thereof is selected from; When nA is 0, L E is not present;
RA, RB, RC, RD, R, 및 R'은 각각 수소, 중수소, 할로겐, 알킬기, 시클로알킬기, 헤테로알킬기, 아릴알킬기, 알콕시기, 아릴옥시기, 아미노기, 실릴기, 알케닐기, 시클로알케닐기, 헤테로알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아실기, 카르보닐기, 카르복실산기, 에스테르기, 니트릴기, 이소니트릴기, 설파닐기, 설피닐기, 설포닐기, 포스피노기, 및 이의 조합으로 이루어진 군에서 독립적으로 선택되고; 임의의 인접 RA, RB, RC, RD, R, 및 R'은 임의 연결되어 고리를 형성하고; XB, XC, XD, 및 XE는 각각 탄소 및 질소로 이루어진 군에서 독립적으로 선택되고; Q1, Q2, Q3, 및 Q4는 각각 산소 또는 직접 결합을 나타낸다.R A , R B , R C , R D , R , and R' are each hydrogen, deuterium, halogen, alkyl group, cycloalkyl group, heteroalkyl group, arylalkyl group, alkoxy group, aryloxy group, amino group, silyl group, alkenyl group , Cycloalkenyl group, heteroalkenyl group, alkynyl group, aryl group, heteroaryl group, acyl group, carbonyl group, carboxylic acid group, ester group, nitrile group, isonitrile group, sulfanyl group, sulfinyl group, sulfonyl group, phosphino group independently selected from the group consisting of, and combinations thereof; any adjacent R A , R B , R C , R D , R , and R' are optionally linked to form a ring; X B , X C , X D , and X E are each independently selected from the group consisting of carbon and nitrogen; Q 1 , Q 2 , Q 3 , and Q 4 each represent an oxygen or a direct bond.
일 실시예에 따른 도펀트는 백금 착물일 수 있으며, 예컨대 하기 화학식 Ⅵ로 표현될 수 있다.A dopant according to an embodiment may be a platinum complex, and may be represented by Chemical Formula VI below.
[화학식 Ⅵ][Formula VI]
Figure PCTKR2023002090-appb-img-000109
Figure PCTKR2023002090-appb-img-000109
상기 화학식 Ⅵ에서,In Formula VI,
X100은 O, S 및 NR131 중에서 선택되고,X 100 is selected from O, S and NR 131 ;
R117 내지 R131은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C10 알킬기, 치환 또는 비치환된 C6 내지 C20 아릴기, 또는 - SiR132R133R134이고,R 117 to R 131 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, a substituted or unsubstituted C6 to C20 aryl group, or - SiR 132 R 133 R 134 ;
상기 R132 내지 R134은 각각 독립적으로 C1 내지 C6 알킬기이고,Wherein R 132 to R 134 are each independently a C1 to C6 alkyl group;
R117 내지 R131중 적어도 하나는 -SiR132R133R134 또는 tert-부틸기이다.At least one of R 117 to R 131 is -SiR 132 R 133 R 134 or a tert-butyl group.
이하 상술한 유기 광전자 소자용 조성물을 적용한 유기 광전자 소자를 설명한다.Hereinafter, organic optoelectronic devices to which the above-described composition for organic optoelectronic devices is applied will be described.
유기 광전자 소자는 전기 에너지와 광 에너지를 상호 전환할 수 있는 소자이면 특별히 한정되지 않으며, 예컨대 유기 광전 소자, 유기 발광 소자, 유기 태양 전지 및 유기 감광체 드럼 등을 들 수 있다.The organic optoelectronic device is not particularly limited as long as it is a device capable of converting electrical energy and light energy, and examples thereof include an organic photoelectric device, an organic light emitting device, an organic solar cell, and an organic photoreceptor drum.
여기서는 유기 광전자 소자의 일 예인 유기 발광 소자를 도면을 참고하여 설명한다.Here, an organic light emitting device, which is an example of an organic optoelectronic device, will be described with reference to drawings.
도 1은 일 구현예에 따른 유기 발광 소자를 보여주는 단면도이다.1 is a cross-sectional view showing an organic light emitting device according to an exemplary embodiment.
도 1을 참고하면, 일 구현예에 따른 유기 발광 소자 (100)는 서로 마주하는 양극(120)과 음극(110), 그리고 양극(120)과 음극(110) 사이에 위치하는 유기층(105)을 포함한다.Referring to FIG. 1 , an organic light emitting device 100 according to an embodiment includes an anode 120 and a cathode 110 facing each other, and an organic layer 105 positioned between the anode 120 and the cathode 110. include
양극(120)은 예컨대 정공 주입이 원활하도록 일 함수가 높은 도전체로 만들어질 수 있으며, 예컨대 금속, 금속 산화물 및/또는 도전성 고분자로 만들어질 수 있다. 양극(120)은 예컨대 니켈, 백금, 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐주석산화물(ITO), 인듐아연산화물(IZO)과 같은 금속 산화물; ZnO와 Al 또는 SnO2와 Sb와 같은 금속과 산화물의 조합; 폴리(3-메틸티오펜), 폴리(3,4-(에틸렌-1,2-디옥시)티오펜)(polyehtylenedioxythiophene: PEDOT), 폴리피롤 및 폴리아닐린과 같은 도전성 고분자 등을 들 수 있으나, 이에 한정되는 것은 아니다. The anode 120 may be made of, for example, a conductor having a high work function so as to smoothly inject holes, and may be made of, for example, metal, metal oxide, and/or conductive polymer. The anode 120 may be formed of, for example, a metal such as nickel, platinum, vanadium, chromium, copper, zinc, or gold or an alloy thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO and Al or SnO 2 and Sb; conductive polymers such as poly(3-methylthiophene), poly(3,4-(ethylene-1,2-dioxy)thiophene) (polyehtylenedioxythiophene: PEDOT), polypyrrole, and polyaniline; It is not.
음극(110)은 예컨대 전자 주입이 원활하도록 일 함수가 낮은 도전체로 만들어질 수 있으며, 예컨대 금속, 금속 산화물 및/또는 도전성 고분자로 만들어질 수 있다. 음극(110)은 예컨대 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 납, 세슘, 바륨 등과 같은 금속 또는 이들의 합금; LiF/Al, LiO2/Al, LiF/Ca, 및 BaF2/Ca과 같은 다층 구조 물질을 들 수 있으나, 이에 한정되는 것은 아니다. The cathode 110 may be made of, for example, a conductor having a low work function so as to facilitate electron injection, and may be made of, for example, metal, metal oxide, and/or conductive polymer. The negative electrode 110 may be formed of, for example, metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, lead, cesium, barium, or alloys thereof; Multi-layered materials such as LiF/Al, LiO 2 /Al, LiF/Ca, and BaF 2 /Ca may be mentioned, but are not limited thereto.
유기층(105)은 전술한 유기 광전자 소자용 조성물을 포함할 수 있다. The organic layer 105 may include the above-described composition for an organic optoelectronic device.
상기 유기층(105)는 발광층(130)을 포함하고, 발광층(130)은 전술한 유기 광전자 소자용 조성물을 포함할 수 있다. The organic layer 105 includes the light emitting layer 130, and the light emitting layer 130 may include the above-described composition for an organic optoelectronic device.
도펀트를 더욱 포함하는 상기 유기 광전자 소자용 조성물은 예컨대 적색 또는 녹색 발광 조성물일 수 있다.The composition for an organic optoelectronic device further comprising a dopant may be, for example, a red or green light emitting composition.
발광층(130)은 예컨대 전술한 유기 광전자 소자용 조성물을 인광 호스트로서 포함할 수 있다.The light emitting layer 130 may include, for example, the aforementioned composition for an organic optoelectronic device as a phosphorescent host.
유기층은 발광층 외에 전하 수송 영역을 더 포함할 수 있다.The organic layer may further include a charge transport region in addition to the light emitting layer.
상기 전하 수송 영역은 예컨대 정공 수송 영역 (140)일 수 있다.The charge transport region may be, for example, the hole transport region 140 .
상기 정공 수송 영역 (140)은 양극(120)과 발광층(130) 사이의 정공 주입 및/또는 정공 이동성을 더욱 높이고 전자를 차단할 수 있다.The hole transport region 140 may further increase hole injection and/or hole mobility between the anode 120 and the light emitting layer 130 and block electrons.
구체적으로 상기 정공 수송 영역(140)은 양극(120)과 발광층(130) 사이의 정공 수송층, 및 상기 발광층(130)과 상기 정공 수송층 사이의 정공 수송 보조층을 포함할 수 있고, 하기 그룹 B에 나열된 화합물 중 적어도 하나는 상기 정공 수송층, 및 정공 수송 보조층 중 적어도 하나의 층에 포함될 수 있다.Specifically, the hole transport region 140 may include a hole transport layer between the anode 120 and the light emitting layer 130, and a hole transport auxiliary layer between the light emitting layer 130 and the hole transport layer. At least one of the listed compounds may be included in at least one of the hole transport layer and the hole transport auxiliary layer.
[그룹 B] [Group B]
Figure PCTKR2023002090-appb-img-000110
Figure PCTKR2023002090-appb-img-000110
Figure PCTKR2023002090-appb-img-000111
Figure PCTKR2023002090-appb-img-000111
Figure PCTKR2023002090-appb-img-000112
Figure PCTKR2023002090-appb-img-000112
Figure PCTKR2023002090-appb-img-000113
Figure PCTKR2023002090-appb-img-000113
Figure PCTKR2023002090-appb-img-000114
Figure PCTKR2023002090-appb-img-000114
Figure PCTKR2023002090-appb-img-000115
Figure PCTKR2023002090-appb-img-000115
Figure PCTKR2023002090-appb-img-000116
Figure PCTKR2023002090-appb-img-000116
Figure PCTKR2023002090-appb-img-000117
Figure PCTKR2023002090-appb-img-000117
Figure PCTKR2023002090-appb-img-000118
Figure PCTKR2023002090-appb-img-000118
Figure PCTKR2023002090-appb-img-000119
Figure PCTKR2023002090-appb-img-000119
Figure PCTKR2023002090-appb-img-000120
Figure PCTKR2023002090-appb-img-000120
Figure PCTKR2023002090-appb-img-000121
Figure PCTKR2023002090-appb-img-000121
Figure PCTKR2023002090-appb-img-000122
Figure PCTKR2023002090-appb-img-000122
Figure PCTKR2023002090-appb-img-000123
Figure PCTKR2023002090-appb-img-000123
Figure PCTKR2023002090-appb-img-000124
Figure PCTKR2023002090-appb-img-000124
Figure PCTKR2023002090-appb-img-000125
Figure PCTKR2023002090-appb-img-000125
Figure PCTKR2023002090-appb-img-000126
Figure PCTKR2023002090-appb-img-000126
Figure PCTKR2023002090-appb-img-000127
Figure PCTKR2023002090-appb-img-000127
Figure PCTKR2023002090-appb-img-000128
Figure PCTKR2023002090-appb-img-000128
Figure PCTKR2023002090-appb-img-000129
Figure PCTKR2023002090-appb-img-000129
Figure PCTKR2023002090-appb-img-000130
Figure PCTKR2023002090-appb-img-000130
Figure PCTKR2023002090-appb-img-000131
Figure PCTKR2023002090-appb-img-000131
Figure PCTKR2023002090-appb-img-000132
Figure PCTKR2023002090-appb-img-000132
상기 정공 수송 영역(140)에는 전술한 화합물 외에도 US5061569A, JP1993-009471A, WO1995-009147A1, JP1995-126615A, JP1998-095973A 등에 기재된 공지의 화합물 및 이와 유사한 구조의 화합물도 사용될 수 있다.In addition to the above compounds, known compounds described in US5061569A, JP1993-009471A, WO1995-009147A1, JP1995-126615A, JP1998-095973A and similar structures may be used for the hole transport region 140.
또한, 상기 전하 수송 영역은 예컨대 전자 수송 영역(150)일 수 있다.Also, the charge transport region may be, for example, the electron transport region 150 .
상기 전자 수송 영역(150)은 음극(110)과 발광층(130) 사이의 전자 주입 및/또는 전자 이동성을 더욱 높이고 정공을 차단할 수 있다.The electron transport region 150 may further increase electron injection and/or electron mobility between the cathode 110 and the light emitting layer 130 and block holes.
구체적으로 상기 전자 수송 영역(150)은 음극(110)과 발광층(130) 사이의 전자 수송층, 및 상기 발광층(130)과 상기 전자 수송층 사이의 전자 수송 보조층을 포함할 수 있고, 하기 그룹 C에 나열된 화합물 중 적어도 하나는 상기 전자 수송층, 및 전자 수송 보조층 중 적어도 하나의 층에 포함될 수 있다.Specifically, the electron transport region 150 may include an electron transport layer between the cathode 110 and the light emitting layer 130, and an electron transport auxiliary layer between the light emitting layer 130 and the electron transport layer. At least one of the listed compounds may be included in at least one of the electron transport layer and the electron transport auxiliary layer.
[그룹 C][Group C]
Figure PCTKR2023002090-appb-img-000133
Figure PCTKR2023002090-appb-img-000133
Figure PCTKR2023002090-appb-img-000134
Figure PCTKR2023002090-appb-img-000134
Figure PCTKR2023002090-appb-img-000135
Figure PCTKR2023002090-appb-img-000135
Figure PCTKR2023002090-appb-img-000136
Figure PCTKR2023002090-appb-img-000136
Figure PCTKR2023002090-appb-img-000137
Figure PCTKR2023002090-appb-img-000137
Figure PCTKR2023002090-appb-img-000138
Figure PCTKR2023002090-appb-img-000138
Figure PCTKR2023002090-appb-img-000139
Figure PCTKR2023002090-appb-img-000139
Figure PCTKR2023002090-appb-img-000140
Figure PCTKR2023002090-appb-img-000140
Figure PCTKR2023002090-appb-img-000141
Figure PCTKR2023002090-appb-img-000141
Figure PCTKR2023002090-appb-img-000142
Figure PCTKR2023002090-appb-img-000142
Figure PCTKR2023002090-appb-img-000143
Figure PCTKR2023002090-appb-img-000143
Figure PCTKR2023002090-appb-img-000144
Figure PCTKR2023002090-appb-img-000144
Figure PCTKR2023002090-appb-img-000145
Figure PCTKR2023002090-appb-img-000145
Figure PCTKR2023002090-appb-img-000146
Figure PCTKR2023002090-appb-img-000146
Figure PCTKR2023002090-appb-img-000147
Figure PCTKR2023002090-appb-img-000147
Figure PCTKR2023002090-appb-img-000148
Figure PCTKR2023002090-appb-img-000148
Figure PCTKR2023002090-appb-img-000149
Figure PCTKR2023002090-appb-img-000149
일 구현예는 유기층으로서 발광층을 포함한 유기 발광 소자일 수 있다.One embodiment may be an organic light emitting device including a light emitting layer as an organic layer.
다른 일 구현예는 유기층으로서 발광층 및 정공 수송 영역을 포함한 유기 발광 소자일 수 있다.Another embodiment may be an organic light emitting device including a light emitting layer and a hole transport region as an organic layer.
또 다른 일 구현예는 유기층으로서 발광층 및 전자 수송 영역을 포함한 유기 발광 소자일 수 있다.Another embodiment may be an organic light emitting device including an emission layer and an electron transport region as an organic layer.
본 발명의 일 구현예에 따른 유기 발광 소자는 도 1에서와 같이 유기층(105)으로서 발광층(130) 외에 정공 수송 영역(140) 및 전자 수송 영역(150)을 포함할 수 있다.As shown in FIG. 1 , an organic light emitting device according to an exemplary embodiment of the present invention may include a hole transport region 140 and an electron transport region 150 in addition to the emission layer 130 as the organic layer 105 .
한편, 유기 발광 소자는 전술한 유기층으로서 발광층 외에 추가로 전자주입층(미도시), 정공주입층(미도시) 등을 더 포함할 수도 있다. Meanwhile, the organic light emitting device may further include an electron injection layer (not shown), a hole injection layer (not shown), and the like in addition to the light emitting layer as the organic layer described above.
유기 발광 소자(100)는 기판 위에 양극 또는 음극을 형성한 후, 진공증착법(evaporation), 스퍼터링(sputtering), 플라즈마 도금 및 이온도금과 같은 건식성막법 등으로 유기층을 형성한 후, 그 위에 음극 또는 양극을 형성하여 제조할 수 있다.In the organic light emitting device 100, after forming an anode or a cathode on a substrate, an organic layer is formed by a dry film method such as evaporation, sputtering, plasma plating, or ion plating, and then a cathode or cathode thereon. It can be manufactured by forming an anode.
상술한 유기 발광 소자는 유기 발광 표시 장치에 적용될 수 있다.The organic light emitting device described above may be applied to an organic light emitting display device.
이하 실시예를 통하여 상술한 구현예를 보다 상세하게 설명한다.  다만 하기의 실시예는 단지 설명의 목적을 위한 것이며 권리범위를 제한하는 것은 아니다.The above-described implementation will be described in more detail through the following examples. However, the following examples are for illustrative purposes only and do not limit the scope of rights.
이하, 실시예 및 합성예에서 사용된 출발물질 및 반응물질은 특별한 언급이 없는 한, Sigma-Aldrich 社, TCI 社, tokyo chemical industry 또는 P&H tech에서 구입하였거나, 공지된 방법을 통해 합성하였다.Hereinafter, the starting materials and reactants used in Examples and Synthesis Examples were purchased from Sigma-Aldrich, TCI, Tokyo chemical industry or P&H tech, or synthesized through known methods, unless otherwise specified.
(유기 광전자 소자용 화합물의 제조)(Preparation of compounds for organic optoelectronic devices)
본 발명의 화합물의 보다 구체적인 예로서 제시된 화합물을 하기 단계를 통해 합성하였다.A compound presented as a more specific example of the compound of the present invention was synthesized through the following steps.
제1 화합물의 합성Synthesis of First Compound
합성예 1: 화합물 A-69의 합성Synthesis Example 1: Synthesis of Compound A-69
[반응식 1][Scheme 1]
Figure PCTKR2023002090-appb-img-000150
Figure PCTKR2023002090-appb-img-000150
a) 중간체 int-1의 합성a) synthesis of intermediate int-1
2-bromo-4-chlorobenzaldehyde (40.0 g, 182.2 mmol), 2-naphthaleneboroni c acid (34.4 g, 200.4 mmol), tetrakis(triphenylphosphine)palladium(0) (10.6 g, 9.2 mmol) 그리고 potassium carbonate (75.6 g, 546.8 mmol)을 tetrahydrofuran : 증류수 = 2 : 1 부피비의 혼합용액 900 mL에 녹이고 80 ℃에서 12시간 동안 환류 교반한다. 반응이 종결되면 컬럼크로마토그래피 (dichloromethane : n-hexane)로 정제하여 int-1을 37.2 g (수율: 76.7 %) 수득하였다.2-bromo-4-chlorobenzaldehyde (40.0 g, 182.2 mmol), 2-naphthaleneboronic acid (34.4 g, 200.4 mmol), tetrakis(triphenylphosphine)palladium(0) (10.6 g, 9.2 mmol) and potassium carbonate (75.6 g, 546.8 mmol) in tetrahydrofuran: distilled water = 2: 1 volume ratio of the mixed solution in 900 mL, and stirred under reflux for 12 hours at 80 ℃. Upon completion of the reaction, 37.2 g of int-1 (yield: 76.7%) was obtained by purification using column chromatography (dichloromethane: n-hexane).
b) 중간체 int-2의 합성b) synthesis of intermediate int-2
int-1 (35.2 g, 132 mmol)과 (methoxymethyl)triphenylphosphonium chloride (49.8 g, 146 mmol)을 tetrahydrofuran 260 mL에 녹이고, 0 ℃에서 potassium tert-butoxide (17.8 g, 158 mmol)을 천천히 넣고 교반한다. 반응이 종결되면 회전 증발기를 이용하여 용매를 모두 제거한다. Dichloromethane과 증류수로 2회 추출하고 유기층을 건조한다. 별도의 추가 정제 없이, dichlromethane 260 mL에 녹이고 0 ℃에서 methanesulfonic acid (25.4 g, 264 mmol)을 천천히 넣고 교반한다. 반응이 종결되면 반응액에 methyl alcohol을 가하여 고체를 석출시키고 1차적으로 여과하고, 그 고체를 toluene에 녹여서 실리카겔 여과/정제하여 int-2를 22.7 g (수율: 65.5 %) 수득하였다.Dissolve int-1 (35.2 g, 132 mmol) and (methoxymethyl)triphenylphosphonium chloride (49.8 g, 146 mmol) in 260 mL of tetrahydrofuran, slowly add potassium tert-butoxide (17.8 g, 158 mmol) at 0 ° C and stir. When the reaction is complete, all solvents are removed using a rotary evaporator. Extract twice with dichloromethane and distilled water and dry the organic layer. Without additional purification, dissolve in dichlromethane 260 mL, slowly add methanesulfonic acid (25.4 g, 264 mmol) at 0 ° C and stir. When the reaction was completed, methyl alcohol was added to the reaction solution to precipitate a solid, which was first filtered, and the solid was dissolved in toluene and filtered/purified on silica gel to obtain 22.7 g of int-2 (yield: 65.5%).
c) 화합물 A-69의 합성c) Synthesis of Compound A-69
int-2 (5.0 g, 19 mmol), 4-(naphthalen-2-yl)-N-phenylaniline (5.6 g, 19 mmol), tris(dibenzylideneacetone)dipalladium(0) (0.9 g, 1 mmol), sodium tert-butoxide (2.7 g, 29 mmol) 그리고 tri-tert-butylphosphine (0.6 g, 3 mmol)을 xylene 95 mL에 넣고 150 ℃에서 12시간 동안 환류 교반하였다. 반응이 완료되면 용액을 과량의 증류수에 넣어서 침전물을 형성시킨다. 침전물을 여과하고 toluene에 끓여 녹여 실리카겔에 여과한다. 여과된 용액을 acetone과 섞어 재결정하여 A-69를 7.7 g (수율: 77.4 %) 수득하였다.int-2 (5.0 g, 19 mmol), 4-(naphthalen-2-yl)-N-phenylaniline (5.6 g, 19 mmol), tris(dibenzylideneacetone)dipalladium(0) (0.9 g, 1 mmol), sodium tert -butoxide (2.7 g, 29 mmol) and tri-tert-butylphosphine (0.6 g, 3 mmol) were added to 95 mL of xylene and stirred under reflux at 150 °C for 12 hours. When the reaction is complete, the solution is poured into an excess of distilled water to form a precipitate. The precipitate is filtered, boiled and dissolved in toluene, and filtered through silica gel. The filtered solution was recrystallized by mixing with acetone to obtain 7.7 g of A-69 (yield: 77.4%).
합성예 2: 화합물 A-71의 합성Synthesis Example 2: Synthesis of Compound A-71
[반응식 2][Scheme 2]
Figure PCTKR2023002090-appb-img-000151
Figure PCTKR2023002090-appb-img-000151
int-2와 N-(4-(naphthalen-2-yl)phenyl)-[1,1'-biphenyl]-2-amine을 출발 물질로 하여 합성예 1의 화합물 A-69 합성법과 동일한 방법으로 합성하여 toluene : acetone 혼합용액으로 재결정하여 화합물 A-71을 수득하였다. (수율: 82.4 %)Synthesis in the same manner as in the synthesis of compound A-69 in Synthesis Example 1 using int-2 and N-(4-(naphthalen-2-yl)phenyl)-[1,1'-biphenyl]-2-amine as starting materials and recrystallized from a mixed solution of toluene: acetone to obtain compound A-71. (Yield: 82.4%)
합성예 3: 화합물 A-79의 합성Synthesis Example 3: Synthesis of Compound A-79
[반응식 3][Scheme 3]
Figure PCTKR2023002090-appb-img-000152
Figure PCTKR2023002090-appb-img-000152
a) 중간체 A-79-1의 합성a) Synthesis of Intermediate A-79-1
4-(naphthalen-2-yl)aniline과 1-bromodibenzofuran을 출발 물질로 하여 합성예 1의 화합물 A-69 합성법과 동일한 방법으로 합성하여 컬럼크로마토그래피로 정제하여 중간체 A-79-1을 수득하였다. (수율: 65.4 %)Compound A-69 was synthesized in the same manner as in Synthesis Example 1 using 4-(naphthalen-2-yl)aniline and 1-bromodibenzofuran as starting materials, and purified by column chromatography to obtain intermediate A-79-1. (Yield: 65.4%)
b) 화합물 A-79의 합성b) Synthesis of Compound A-79
A-79-1과 int-2를 출발 물질로 하여 합성예 1의 화합물 A-69의 합성법과 동일한 방법으로 합성하여 toluene으로 재결정하여 화합물 A-79을 수득하였다. (수율: 59.8 %)A-79-1 and int-2 were synthesized in the same manner as in Synthesis Example 1 for the synthesis of compound A-69 using int-2 as starting materials, and recrystallized with toluene to obtain compound A-79. (Yield: 59.8%)
합성예 4: 화합물 A-158의 합성Synthesis Example 4: Synthesis of Compound A-158
[반응식 4][Scheme 4]
Figure PCTKR2023002090-appb-img-000153
Figure PCTKR2023002090-appb-img-000153
a) 중간체 A-158-1의 합성a) Synthesis of Intermediate A-158-1
1-bromo-4-chloro-2-fluorobenzene (50.0 g, 239 mmol), 1-naphthol (37.9 g, 267 mmol) 그리고 potassium carbonate (99.0 g, 716 mmol)을 N-methyl-2-pyrrolidinone 1200 mL에 넣고 180 ℃에서 12시간 동안 환류 교반하였다. 반응이 완료되면 용액을 과량의 증류수에 넣어서 침전물을 형성시킨다. 침전물을 여과하고 dichloromethane에 녹여 실리카겔에 여과한다. 여과된 용액을 n-hexane과 섞어 재결정하여 중간체 A-158-1을 53.5 g (수율: 67.2 %) 수득하였다.1-bromo-4-chloro-2-fluorobenzene (50.0 g, 239 mmol), 1-naphthol (37.9 g, 267 mmol) and potassium carbonate (99.0 g, 716 mmol) were added to 1200 mL of N-methyl-2-pyrrolidinone. The mixture was stirred under reflux at 180 °C for 12 hours. When the reaction is complete, the solution is poured into an excess of distilled water to form a precipitate. The precipitate is filtered, dissolved in dichloromethane, and filtered through silica gel. The filtered solution was recrystallized by mixing with n-hexane to obtain 53.5 g of intermediate A-158-1 (yield: 67.2%).
b) 중간체 A-158-2의 합성b) Synthesis of Intermediate A-158-2
중간체 A-158-1 (53.5 g, 160 mmol), palladium(II) acetate (1.8 g, 8 mmol), tricyclohexylphosphine tetrafluoroborate (9.3 g, 24 mmol) 그리고 potassium carbonate (44.3 g, 321 mmol)을 dimethylacetamide 800 mL에 넣고 180 ℃에서 12시간 동안 환류 교반하였다. 반응이 완료되면 용액을 과량의 증류수에 넣어서 침전물을 형성시킨다. 침전물을 여과하고 dichloromethane에 녹여 실리카겔에 여과한다. 여과된 용액을 n-hexane과 섞어 재결정하여 중간체 A-158-2를 53.5 g (수율: 67.2 %) 수득하였다.Intermediate A-158-1 (53.5 g, 160 mmol), palladium(II) acetate (1.8 g, 8 mmol), tricyclohexylphosphine tetrafluoroborate (9.3 g, 24 mmol) and potassium carbonate (44.3 g, 321 mmol) were mixed with dimethylacetamide 800 mL. and stirred under reflux at 180 °C for 12 hours. When the reaction is complete, the solution is poured into an excess of distilled water to form a precipitate. The precipitate is filtered, dissolved in dichloromethane, and filtered through silica gel. The filtered solution was recrystallized by mixing with n-hexane to obtain 53.5 g of intermediate A-158-2 (yield: 67.2%).
c) 중간체 A-158-3의 합성c) Synthesis of Intermediate A-158-3
중간체 A-158-2와 2-aminobiphenyl을 출발 물질로 하여 합성예 1의 화합물 A-69 합성법과 동일한 방법으로 합성하여 컬럼크로마토그래피로 정제하여 중간체 A-158-3을 수득하였다. (수율: 71.0 %)Intermediate A-158-2 and 2-aminobiphenyl were synthesized in the same manner as in Synthesis Example 1 of Compound A-69 synthesis using 2-aminobiphenyl as starting materials, and purified by column chromatography to obtain Intermediate A-158-3. (Yield: 71.0%)
d) 화합물 A-158의 합성d) Synthesis of Compound A-158
중간체 A-158-3과 int-2를 출발 물질로 하여 합성예 1의 화합물 A-69 합성법과 동일한 방법으로 합성하여 toluene으로 재결정하여 화합물 A-158을 수득하였다. (수율: 66.5 %)Intermediate A-158-3 and int-2 were synthesized in the same manner as in the synthesis of compound A-69 in Synthesis Example 1 using int-2 as starting materials, and recrystallized from toluene to obtain compound A-158. (Yield: 66.5%)
합성예 5: 화합물 A-166의 합성Synthesis Example 5: Synthesis of Compound A-166
[반응식 5][Scheme 5]
Figure PCTKR2023002090-appb-img-000154
Figure PCTKR2023002090-appb-img-000154
a) 중간체 A-166-1의 합성a) Synthesis of Intermediate A-166-1
중간체 A-158-2 (20.0 g, 79 mmol), lithium bis(trimethylsilyl)amide solution (95 mmol), tris(dibenzylideneacetone)dipalladium(0) (2.2 g, 2 mmol) 그리고 tri-tert-butylphosphine (1.4 g, 7 mmol)을 toluene 400 mL에 넣고 110 ℃ 에서 12시간 동안 환류 교반하였다. 반응이 완료되면 상온에서 묽은 염산 수용액을 가하고 약 30분동안 교반한다. 석출된 고체를 여과하고, sodium hydroxide 수용액을 가하여 용액을 중화시키고 약 30분동안 교반한다. Dichloromethane : 증류수로 2회 추출하고, 유기층을 실리카겔에 여과한다. 여과된 용액을 n-hexane과 섞어 재결정하여 중간체 A-166-1을 13.2 g (수율: 71.4 %) 수득하였다.Intermediate A-158-2 (20.0 g, 79 mmol), lithium bis(trimethylsilyl)amide solution (95 mmol), tris(dibenzylideneacetone)dipalladium(0) (2.2 g, 2 mmol) and tri-tert-butylphosphine (1.4 g , 7 mmol) was added to 400 mL of toluene and stirred under reflux at 110 °C for 12 hours. When the reaction is complete, dilute aqueous hydrochloric acid solution is added at room temperature and stirred for about 30 minutes. Filter the precipitated solid, add sodium hydroxide solution to neutralize the solution, and stir for about 30 minutes. Dichloromethane: Extract twice with distilled water, and filter the organic layer through silica gel. The filtered solution was recrystallized by mixing with n-hexane to obtain 13.2 g of intermediate A-166-1 (yield: 71.4%).
b) 중간체 A-166-2의 합성b) synthesis of intermediate A-166-2
A-166-1과 1-bromodibenzofuran을 출발 물질로 하여 합성예 1의 화합물 A-69 합성법과 동일한 방법으로 합성하여 컬럼크로마토그래피로 정제하여 중간체 A-166-2를 수득하였다. (수율: 65.1 %)A-166-1 and 1-bromodibenzofuran were synthesized in the same manner as in the synthesis of compound A-69 in Synthesis Example 1 using 1-bromodibenzofuran as starting materials, and purified by column chromatography to obtain intermediate A-166-2. (Yield: 65.1%)
c) 화합물 A-166의 합성c) Synthesis of Compound A-166
중간체 A-166-2과 int-2를 출발 물질로 하여 합성예 1의 화합물 A-69 합성법과 동일한 방법으로 합성하여 toluene으로 재결정하여 화합물 A-166을 수득하였다. (수율: 59.9 %)Intermediate A-166-2 and int-2 were synthesized in the same manner as in the synthesis of compound A-69 in Synthesis Example 1 using int-2 as starting materials, and recrystallized from toluene to obtain compound A-166. (Yield: 59.9%)
비교합성예 1: 화합물 H1의 합성Comparative Synthesis Example 1: Synthesis of Compound H1
[반응식 6][Scheme 6]
Figure PCTKR2023002090-appb-img-000155
Figure PCTKR2023002090-appb-img-000155
a) 중간체 H1-1의 합성a) Synthesis of Intermediate H1-1
(2-phenylbenzo[d]oxazol-7-yl)boronic acid과 2-bromo-4-chlorobenzaldeh yde을 출발 물질로 하여 합성예 1의 중간체 int-1 합성법과 동일한 방법으로 합성하여 컬럼크로마토그래피로 정제하여 중간체 H1-1을 수득하였다. (수율: 72.0 %)(2-phenylbenzo[d]oxazol-7-yl)boronic acid and 2-bromo-4-chlorobenzaldeh yde as starting materials were synthesized in the same manner as in the synthesis of intermediate int-1 in Synthesis Example 1, and purified by column chromatography. Intermediate H1-1 was obtained. (Yield: 72.0%)
b) 중간체 H1-2의 합성b) synthesis of intermediate H1-2
중간체 H1-1을 출발 물질로 하여 합성예 1의 중간체 int-2 합성법과 동일한 방법으로 합성하여 toluene으로 재결정하여 중간체 H1-2를 수득하였다. (수율: 39.5 %)Intermediate H1-1 was synthesized in the same manner as the synthesis method of intermediate int-2 in Synthesis Example 1 using intermediate H1-1 as a starting material, and recrystallized from toluene to obtain intermediate H1-2. (Yield: 39.5%)
c) 화합물 H1의 합성c) synthesis of compound H1
중간체 H1-2과 N-([1,1'-biphenyl]-2-yl)dibenzo[b,d]thiophen-2-amine을 출발 물질로 하여 합성예 1의 화합물 A-69 합성법과 동일한 방법으로 합성하여 toluene으로 재결정하여 화합물 H1을 수득하였다. (수율: 67.2 %)Intermediate H1-2 and N-([1,1'-biphenyl]-2-yl)dibenzo[b,d]thiophen-2-amine were used as starting materials to synthesize compound A-69 in Synthesis Example 1 by the same method. It was synthesized and recrystallized from toluene to obtain compound H1. (Yield: 67.2%)
비교합성예 2: 화합물 H2의 합성Comparative Synthesis Example 2: Synthesis of Compound H2
[반응식 7][Scheme 7]
Figure PCTKR2023002090-appb-img-000156
Figure PCTKR2023002090-appb-img-000156
a) 중간체 H2-1의 합성a) Synthesis of Intermediate H2-1
(2-phenylbenzo[d]oxazol-7-yl)boronic acid과 2-bromo-5-chlorobenzaldeh yde을 출발 물질로 하여 합성예 1의 중간체 int-1 합성법과 동일한 방법으로 합성하여 컬럼크로마토그래피로 정제하여 중간체 H2-1을 수득하였다. (수율: 77.4 %)(2-phenylbenzo[d]oxazol-7-yl)boronic acid and 2-bromo-5-chlorobenzaldeh yde were synthesized in the same manner as in the synthesis of intermediate int-1 in Synthesis Example 1 using boronic acid and 2-bromo-5-chlorobenzaldeh yde as starting materials and purified by column chromatography. Intermediate H2-1 was obtained. (Yield: 77.4%)
b) 중간체 H2-2의 합성b) synthesis of intermediate H2-2
중간체 H2-1을 출발 물질로 하여 합성예 1의 중간체 int-2 합성법과 동일한 방법으로 합성하여 monochlorobenzene으로 재결정하여 중간체 H2-2를 수득하였다. (수율: 42.1 %)Intermediate H2-1 was synthesized in the same manner as the synthesis of intermediate int-2 in Synthesis Example 1 using intermediate H2-1 as a starting material, and recrystallized from monochlorobenzene to obtain intermediate H2-2. (Yield: 42.1%)
c) 화합물 H2의 합성c) synthesis of compound H2
중간체 H2-2와 di([1,1'-biphenyl]-4-yl)amine을 출발 물질로 하여 합성예 1의 화합물 A-69 합성법과 동일한 방법으로 합성하여 monochlorobenzene으로 재결정하여 화합물 H2를 수득하였다. (수율: 55.3 %)Intermediate H2-2 and di([1,1'-biphenyl]-4-yl)amine were synthesized in the same manner as in Synthesis Example 1 of Compound A-69 synthesis using di([1,1'-biphenyl]-4-yl)amine as starting materials, and recrystallized from monochlorobenzene to obtain compound H2. . (Yield: 55.3%)
제2 화합물의 합성Synthesis of Second Compound
합성예 6 내지 9의 합성Synthesis of Synthesis Examples 6 to 9
표 1의 중간체 A와 중간체 B를 출발 물질로 하여 합성예 1의 int-1, 및 int-2의 합성법과 동일한 방법으로 합성하여 합성예 6 내지 9의 화합물 (int-3 내지 int-6)을 합성하였다.Compounds (int-3 to int-6) of Synthesis Examples 6 to 9 were obtained by synthesizing in the same manner as the synthesis method of int-1 and int-2 of Synthesis Example 1 using Intermediate A and Intermediate B of Table 1 as starting materials. synthesized.
합성예synthesis example 중간체 AIntermediate A 중간체 BIntermediate B 생성 중간체production intermediates 수득량
(수율)
yield
(transference number)
합성예 6Synthesis Example 6
Figure PCTKR2023002090-appb-img-000157
Figure PCTKR2023002090-appb-img-000157
Figure PCTKR2023002090-appb-img-000158
Figure PCTKR2023002090-appb-img-000158
Figure PCTKR2023002090-appb-img-000159

int-3
Figure PCTKR2023002090-appb-img-000159

int-3
13.5 g (55.7 %)13.5 g (55.7%)
합성예 7Synthesis Example 7
Figure PCTKR2023002090-appb-img-000160
Figure PCTKR2023002090-appb-img-000160
Figure PCTKR2023002090-appb-img-000161
Figure PCTKR2023002090-appb-img-000161
Figure PCTKR2023002090-appb-img-000162

int-4
Figure PCTKR2023002090-appb-img-000162

int-4
8.8 g
(49.8 %)
8.8g
(49.8%)
합성예 8Synthesis Example 8
Figure PCTKR2023002090-appb-img-000163
Figure PCTKR2023002090-appb-img-000163
Figure PCTKR2023002090-appb-img-000164
Figure PCTKR2023002090-appb-img-000164
Figure PCTKR2023002090-appb-img-000165

int-5
Figure PCTKR2023002090-appb-img-000165

int-5
11.4 g
(55.2 %)
11.4g
(55.2%)
합성예 9Synthesis Example 9
Figure PCTKR2023002090-appb-img-000166
Figure PCTKR2023002090-appb-img-000166
Figure PCTKR2023002090-appb-img-000167
Figure PCTKR2023002090-appb-img-000167
Figure PCTKR2023002090-appb-img-000168

int-6
Figure PCTKR2023002090-appb-img-000168

int-6
16.5 g
(52.4 %)
16.5g
(52.4%)
합성예 10: 화합물 B-4의 합성Synthesis Example 10: Synthesis of Compound B-4
[반응식 8][Scheme 8]
Figure PCTKR2023002090-appb-img-000169
Figure PCTKR2023002090-appb-img-000169
a) 중간체 B-4-1의 합성a) Synthesis of Intermediate B-4-1
int-3 (30.0 g, 114 mmol), bis(pinacolato)diboron (37.7 g, 148 mmol), [1,1'bis(diphenylphosphino)ferrocene]palladium(II) dichloride (4.7 g, 5.7 mmol), potassium acetate (33.6 g, 343 mmol) 그리고 tricyclohexylphosphine (6.4 g, 23 mmol)을 N,N-dimethylformamide 600 mL에 넣고 140 ℃에서 12시간 동안 환류 교반한다. 반응이 완료되면 과량의 증류수에 부어서 고체를 완전히 석출시킨다. 석출된 고체를 여과하고, 그 고체를 toluene에 끓여 녹여서 실리카겔에 다시 여과한다. 여과된 용액을 재결정하여 중간체 B-4-1을 30.4 g (수율: 75.2 %) 수득하였다.int-3 (30.0 g, 114 mmol), bis(pinacolato)diboron (37.7 g, 148 mmol), [1,1'bis(diphenylphosphino)ferrocene]palladium(II) dichloride (4.7 g, 5.7 mmol), potassium acetate (33.6 g, 343 mmol) and tricyclohexylphosphine (6.4 g, 23 mmol) were added to 600 mL of N , N -dimethylformamide and stirred under reflux at 140 °C for 12 hours. When the reaction is complete, the solid is completely precipitated by pouring into an excess of distilled water. Filter the precipitated solid, boil and dissolve the solid in toluene, and filter again through silica gel. The filtered solution was recrystallized to obtain 30.4 g (yield: 75.2%) of intermediate B-4-1.
b) 화합물 B-4의 합성b) synthesis of compound B-4
중간체 B-4-1과 2-([1,1'-biphenyl]-3-yl)-4-chloro-6-phenyl-1,3,5-triazine을 출발 물질로 하여 합성예 1의 중간체 int-1 합성법과 동일한 방법으로 합성하여 monochlorobenzene으로 재결정하여 화합물 B-4를 수득하였다. (수율: 88.3 %)Intermediate B-4-1 and 2-([1,1'-biphenyl]-3-yl)-4-chloro-6-phenyl-1,3,5-triazine as starting materials Intermediate of Synthesis Example 1 int Compound B-4 was obtained by recrystallization from monochlorobenzene after synthesis in the same manner as -1 synthesis method. (Yield: 88.3%)
합성예 11: 화합물 B-11의 합성Synthesis Example 11: Synthesis of Compound B-11
[반응식 9][Scheme 9]
Figure PCTKR2023002090-appb-img-000170
Figure PCTKR2023002090-appb-img-000170
중간체 B-4-1과 2-chloro-4-(dibenzo[b,d]furan-1-yl)-6-phenyl-1,3,5-triazine을 출발 물질로 하여 합성예 1의 중간체 int-1 합성법과 동일한 방법으로 합성하여 monochlorobenzene으로 재결정하여 화합물 B-11을 수득하였다. (수율: 80.5 %)Intermediate int- It was synthesized in the same manner as in Synthesis Method 1 and recrystallized from monochlorobenzene to obtain compound B-11. (Yield: 80.5%)
합성예 12: 화합물 B-111의 합성Synthesis Example 12: Synthesis of Compound B-111
[반응식 10][Scheme 10]
Figure PCTKR2023002090-appb-img-000171
Figure PCTKR2023002090-appb-img-000171
a) 중간체 B-111-1의 합성a) Synthesis of Intermediate B-111-1
int-2를 출발 물질로 하여 합성예 10의 중간체 B-4-1의 합성법과 동일한 방법으로 합성하여 dichloromethane : n-hexane 혼합용액으로 재결정하여 중간체 B-111-1을 수득하였다. (수율: 57.4 %)Intermediate B-4-1 was synthesized using int-2 as a starting material and recrystallized from a dichloromethane: n -hexane mixed solution to obtain intermediate B-111-1. (Yield: 57.4%)
b) 화합물 B-111의 합성b) synthesis of compound B-111
중간체 B-111-1과 2-chloro-4-(dibenzo[b,d]furan-1-yl)-6-phenyl-1,3,5-triazine을 출발 물질로 하여 합성예 1의 중간체 int-1 합성법과 동일한 방법으로 합성하여 monochlorobenzene으로 재결정하여 화합물 B-111을 수득하였다. (수율: 75.9 %)Int- It was synthesized in the same manner as in Synthesis Method 1 and recrystallized from monochlorobenzene to obtain compound B-111. (Yield: 75.9%)
합성예 13: 화합물 B-170의 합성Synthesis Example 13: Synthesis of Compound B-170
[반응식 11][Scheme 11]
Figure PCTKR2023002090-appb-img-000172
Figure PCTKR2023002090-appb-img-000172
a) 화합물 B-170-1의 합성a) Synthesis of Compound B-170-1
int-4를 출발 물질로 하여 합성예 10의 중간체 B-4-1의 합성법과 동일한 방법으로 합성하여 dichloromethane : n-hexane 혼합용액으로 재결정하여 중간체 B-170-1을 수득하였다. (수율: 65.2 %)Intermediate B-4-1 was synthesized in the same manner as in Synthesis Example 10 using int-4 as a starting material and recrystallized from a mixed solution of dichloromethane: n -hexane to obtain intermediate B-170-1. (Yield: 65.2%)
b) 화합물 B-170의 합성b) synthesis of compound B-170
중간체 B-170-1과 2-chloro-4-(dibenzo[b,d]furan-1-yl)-6-phenyl-1,3,5-triazine을 출발 물질로 하여 합성예 1의 중간체 int-1 합성법과 동일한 방법으로 합성하여 toluene으로 재결정하여 화합물 B-170을 수득하였다. (수율: 69.5 %)Intermediate int- It was synthesized in the same manner as in Synthesis Method 1 and recrystallized from toluene to obtain compound B-170. (Yield: 69.5%)
합성예 14: 화합물 B-187의 합성Synthesis Example 14: Synthesis of Compound B-187
[반응식 12][Scheme 12]
Figure PCTKR2023002090-appb-img-000173
Figure PCTKR2023002090-appb-img-000173
a) 중간체 B-187-1의 합성a) Synthesis of Intermediate B-187-1
int-5를 출발 물질로 하여 합성예 10의 중간체 B-4-1의 합성법과 동일한 방법으로 합성하여 dichloromethane : n-hexane 혼합용액으로 재결정하여 중간체 B-187-1을 수득하였다. (수율: 70.0 %)Intermediate B-4-1 was synthesized in the same manner as in Synthesis Example 10 using int-5 as a starting material and recrystallized from a mixed solution of dichloromethane: n -hexane to obtain intermediate B-187-1. (Yield: 70.0 %)
b) 화합물 B-187의 합성b) synthesis of compound B-187
중간체 B-187-1과 2-chloro-4-(dibenzo[b,d]furan-1-yl)-6-phenyl-1,3,5-triazine을 출발 물질로 하여 합성예 1의 중간체 int-1 합성법과 동일한 방법으로 합성하여 monochlorobenzene으로 재결정하여 화합물 B-187을 수득하였다. (수율: 55.9%)Int- It was synthesized in the same manner as in Synthesis Method 1 and recrystallized from monochlorobenzene to obtain compound B-187. (Yield: 55.9%)
합성예 15: 화합물 B-188의 합성Synthesis Example 15: Synthesis of Compound B-188
[반응식 13][Scheme 13]
Figure PCTKR2023002090-appb-img-000174
Figure PCTKR2023002090-appb-img-000174
a) 중간체 B-188-1의 합성a) Synthesis of Intermediate B-188-1
int-6을 출발 물질로 하여 합성예 10의 중간체 B-4-1의 합성법과 동일한 방법으로 합성하여 dichloromethane : n-hexane 혼합용액으로 재결정하여 중간체 B-188-1을 수득하였다. (수율: 70.0 %)Intermediate B-4-1 was synthesized in the same manner as in Synthesis Example 10 using int-6 as a starting material and recrystallized from a mixed solution of dichloromethane: n -hexane to obtain intermediate B-188-1. (Yield: 70.0 %)
b) 화합물 B-188의 합성b) synthesis of compound B-188
중간체 B-188-1과 2-chloro-4-(dibenzo[b,d]furan-1-yl)-6-phenyl-1,3,5-triazine을 출발 물질로 하여 합성예 1의 중간체 int-1 합성법과 동일한 방법으로 합성하여 toluene으로 재결정하여 화합물 B-188을 수득하였다. (수율: 79.6%)Int- It was synthesized in the same manner as in Synthesis Method 1 and recrystallized from toluene to obtain compound B-188. (Yield: 79.6%)
합성예 16: 화합물 B-203의 합성Synthesis Example 16: Synthesis of Compound B-203
[반응식 14][Scheme 14]
Figure PCTKR2023002090-appb-img-000175
Figure PCTKR2023002090-appb-img-000175
4,4,5,5-tetramethyl-2-(triphenylen-2-yl)-1,3,2-dioxaborolane과 2-chloro-4-(4-(naphthalen-2-yl)phenyl)-6-phenyl-1,3,5-triazine을 출발 물질로 하여 합성예 1의 중간체 int-1 합성법과 동일한 방법으로 합성하여 dichlorobenzene으로 재결정하여 화합물 B-203을 수득하였다. (수율: 77.2 %)4,4,5,5-tetramethyl-2-(triphenylen-2-yl)-1,3,2-dioxaborolane and 2-chloro-4-(4-(naphthalen-2-yl)phenyl)-6-phenyl Compound B-203 was obtained by recrystallizing from dichlorobenzene after synthesizing -1,3,5-triazine as a starting material in the same manner as in the synthesis of intermediate int-1 in Synthesis Example 1. (Yield: 77.2%)
비교합성예 3: 화합물 H3의 합성Comparative Synthesis Example 3: Synthesis of Compound H3
[반응식 15][Scheme 15]
Figure PCTKR2023002090-appb-img-000176
Figure PCTKR2023002090-appb-img-000176
2,9-dichloro-4,7-diphenyl-1,10-phenanthroline과 9-(3-(4,4,5,5-tetrame thyl-1,3,2-dioxaborolan-2-yl)phenyl)-9H-carbazole 2당량을 출발 물질로 하여 합성예 1의 중간체 int-1 합성법과 동일한 방법으로 합성하여 monochlorobenzene으로 재결정하여 화합물 H3을 수득하였다. (수율: 53.1 %)2,9-dichloro-4,7-diphenyl-1,10-phenanthroline and 9-(3-(4,4,5,5-tetrame thyl-1,3,2-dioxaborolan-2-yl)phenyl)- Compound H3 was obtained by recrystallizing from monochlorobenzene by synthesizing in the same manner as in the synthesis method of intermediate int-1 of Synthesis Example 1 using 2 equivalents of 9H-carbazole as a starting material. (Yield: 53.1%)
(유기 발광 소자의 제작)(Manufacture of organic light emitting device)
실시예 1Example 1
ITO (Indium tin oxide)로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 플라즈마 세정기로 이송시킨 다음 산소 플라즈마를 이용하여 상기 기판을 10분간 세정한 후 진공 증착기로 기판을 이송하였다. 이렇게 준비된 ITO 투명 전극을 양극으로 사용하여 ITO 기판 상부에 3 % NDP-9 (Novaled社로부터 시판됨)으로 도핑된 화합물 A을 진공 증착하여 100 Å 두께의 정공주입층을 형성하고, 상기 정공주입층의 상부에 화합물 A를 1350 Å 두께로 증착하여 정공수송층을 형성하였다. 상기 정공수송층 상부에 화합물 B를 350Å의 두께로 증착하여 정공수송보조층을 형성하고, 정공수송보조층 상부에 합성예 1에서 얻어진 화합물 A-69 및 합성예 10에서 얻어진 화합물 B-4를 호스트로 사용하고 도판트로 PhGD를 10wt%로 도핑하여 진공 증착으로 400Å 두께의 발광층을 형성하였으며, 여기서 화합물 A-69 및 화합물 B-4는 5:5의 중량비로 사용되었다. 이어서 상기 발광층 상부에 화합물 C를 50 Å의 두께로 증착하여 전자수송보조층을 형성하고, 화합물 D와 Liq를 동시에 1:1의 중량비로 진공 증착하여 300 Å 두께의 전자수송층을 형성하였다. 상기 전자수송층 상부에 LiQ 15 Å과 Al 1200 Å을 순차적으로 진공 증착하여 음극을 형성함으로써 유기발광소자를 제작하였다.A glass substrate coated with ITO (Indium tin oxide) was washed with ultrasonic waves in distilled water. After the distilled water cleaning was completed, the substrate was ultrasonically cleaned with a solvent such as isopropyl alcohol, acetone, or methanol, dried, transferred to a plasma cleaner, cleaned for 10 minutes using oxygen plasma, and then transferred to a vacuum evaporator. Using the prepared ITO transparent electrode as an anode, compound A doped with 3% NDP-9 (commercially available from Novaled) was vacuum deposited on the ITO substrate to form a hole injection layer having a thickness of 100 Å, and the hole injection layer Compound A was deposited to a thickness of 1350 Å on top to form a hole transport layer. Compound B was deposited on top of the hole transport layer to a thickness of 350 Å to form a hole transport auxiliary layer, and Compound A-69 obtained in Synthesis Example 1 and Compound B-4 obtained in Synthesis Example 10 were used as hosts on the hole transport auxiliary layer. and 10wt% PhGD was doped as a dopant to form a light emitting layer having a thickness of 400 Å by vacuum deposition, where Compound A-69 and Compound B-4 were used in a weight ratio of 5:5. Subsequently, compound C was deposited on the light emitting layer to a thickness of 50 Å to form an electron transport auxiliary layer, and compound D and Liq were simultaneously vacuum deposited in a weight ratio of 1: 1 to form an electron transport layer with a thickness of 300 Å. An organic light emitting device was fabricated by forming a cathode by sequentially vacuum depositing 15 Å of LiQ and 1200 Å of Al on the electron transport layer.
ITO / 화합물A (3 % NDP-9 doping, 100Å) / 화합물A (1350 Å) / 화합물B (350Å) / EML[화합물 A-69 및 화합물 B-4(90wt%) : PhGD (10wt%)] (400Å) / 화합물C (50Å) / 화합물D : LiQ (300Å) / LiQ (15Å) / Al (1200Å)의 구조로 제작하였다.ITO / Compound A (3% NDP-9 doping, 100Å) / Compound A (1350 Å) / Compound B (350Å) / EML [Compound A-69 and Compound B-4 (90wt%): PhGD (10wt%)] (400Å) / Compound C (50Å) / Compound D: LiQ (300Å) / LiQ (15Å) / Al (1200Å).
화합물 A: N-(biphenyl-4-yl)-9,9-dimethyl-N-(4-(9-phenyl-9H-carbazol-3-yl)phenyl)-9H-fluoren-2-amineCompound A: N-(biphenyl-4-yl)-9,9-dimethyl-N-(4-(9-phenyl-9H-carbazol-3-yl)phenyl)-9H-fluoren-2-amine
화합물 B: N,N-bis(9,9-dimethyl-9H-fluoren-4-yl)-9,9-spirobi(fluorene)-2-amineCompound B: N,N-bis(9,9-dimethyl-9H-fluoren-4-yl)-9,9-spirobi(fluorene)-2-amine
화합물 C: 2-[3'-(9,9-Dimethyl-9H-fluoren-2-yl)[1,1'-biphenyl]-3-yl]-4,6-diphenyl-1,3,5-triazineCompound C: 2-[3'-(9,9-Dimethyl-9H-fluoren-2-yl)[1,1'-biphenyl]-3-yl]-4,6-diphenyl-1,3,5- triazines
화합물 D: 2-[4-[4-(4'-Cyano-1,1'-biphenyl-4-yl)-1-naphthyl]phenyl]-4,6-diphenyl-1,3,5-triazineCompound D: 2-[4-[4-(4'-Cyano-1,1'-biphenyl-4-yl)-1-naphthyl]phenyl]-4,6-diphenyl-1,3,5-triazine
[PhGD] [PhGD]
Figure PCTKR2023002090-appb-img-000177
Figure PCTKR2023002090-appb-img-000177
실시예 2 내지 19 및 비교예 1 내지 4Examples 2 to 19 and Comparative Examples 1 to 4
하기 표 2에 기재한 바와 같이 호스트를 변경한 것을 제외하고는, 상기 실시예 2와 동일한 방법으로 실시예 2 내지 19 및 비교예 1 내지 4의 소자를 제작하였다.Devices of Examples 2 to 19 and Comparative Examples 1 to 4 were fabricated in the same manner as in Example 2, except that the host was changed as shown in Table 2 below.
평가evaluation
(1) 전압변화에 따른 전류밀도의 변화 측정(1) Measurement of change in current density according to voltage change
제조된 유기발광소자에 대해, 전압을 0V 부터 10V까지 상승시키면서 전류-전압계(Keithley 2400)를 이용하여 단위소자에 흐르는 전류값을 측정하고, 측정된 전류값을 면적으로 나누어 결과를 얻었다.With respect to the manufactured organic light emitting device, while increasing the voltage from 0V to 10V, a current value flowing through the unit device was measured using a current-voltmeter (Keithley 2400), and the result was obtained by dividing the measured current value by the area.
(2) 전압변화에 따른 휘도 변화 측정(2) Measurement of luminance change according to voltage change
제조된 유기발광소자에 대해, 전압을 0V 부터 10V까지 상승시키면서 휘도계(Minolta Cs-1000A)를 이용하여 그 때의 휘도를 측정하여 결과를 얻었다.The result was obtained by measuring the luminance of the manufactured organic light emitting device using a luminance meter (Minolta Cs-1000A) while increasing the voltage from 0V to 10V.
(3) 발광 효율 측정(3) Measurement of luminous efficiency
상기(1) 및 (2)로부터 측정된 휘도와 전류밀도를 이용하여 동일 전류밀도(10 mA/cm2)의 발광 효율(cd/A)을 계산하였다. Luminous efficiency (cd/A) of the same current density (10 mA/cm 2 ) was calculated using the luminance and current density measured from (1) and (2) above.
비교예 1의 발광 효율을 기준으로 한 상대 값을 하기 표 2에 나타내었다.Relative values based on the luminous efficiency of Comparative Example 1 are shown in Table 2 below.
(4) 수명 측정(4) life measurement
제조된 유기발광소자에 대해 폴라로닉스 수명측정 시스템을 사용하여 초기휘도(cd/m2)를 24,000cd/m2로 발광시키고 시간경과에 따른 휘도의 감소를 측정하여 초기 휘도 대비 95%로 휘도가 감소된 시점을 T95 수명으로 측정하였다.For the manufactured organic light emitting device, the initial luminance (cd/m 2 ) was emitted at 24,000 cd/m 2 using the Polaronics lifetime measurement system, and the decrease in luminance over time was measured, and the luminance was 95% compared to the initial luminance. The reduced time point was measured as the T95 lifetime.
비교예 1의 T95 수명을 기준으로 한 상대 값을 하기 표 2에 나타내었다.Relative values based on the T95 lifetime of Comparative Example 1 are shown in Table 2 below.
(5) 구동전압 측정(5) Driving voltage measurement
전류-전압계(Keithley 2400)를 이용하여 15mA/cm2에서 각 소자의 구동 전압을 측정하여 결과를 얻었다.The result was obtained by measuring the driving voltage of each device at 15 mA/cm 2 using a current-voltmeter (Keithley 2400).
비교예 1의 구동 전압을 기준으로 한 상대 값을 하기 표 2에 나타내었다.Relative values based on the driving voltage of Comparative Example 1 are shown in Table 2 below.
제1호스트1st host 제2호스트2nd host 구동전압
(%)
drive voltage
(%)
발광 효율 (%)Luminous Efficiency (%) 수명 T95
(%)
Lifetime T95
(%)
실시예 1Example 1 A-69A-69 B-4B-4 9696 102102 333333
실시예 2Example 2 A-69A-69 B-11B-11 9494 107107 267267
실시예 3Example 3 A-69A-69 B-111B-111 9494 110110 267267
실시예 4Example 4 A-69A-69 B-170B-170 9494 109109 250250
실시예 5Example 5 A-69A-69 B-187B-187 9393 107107 283283
실시예 6Example 6 A-69A-69 B-188B-188 9494 109109 250250
실시예 7Example 7 A-69A-69 B-203B-203 9191 101101 300300
실시예 8Example 8 A-71A-71 B-4B-4 9797 102102 350350
실시예 9Example 9 A-71A-71 B-11B-11 9494 107107 283283
실시예 10Example 10 A-71A-71 B-111B-111 9494 110110 283283
실시예 11Example 11 A-79A-79 B-4B-4 9797 103103 333333
실시예 12Example 12 A-79A-79 B-170B-170 9595 110110 267267
실시예 13Example 13 A-79A-79 B-187B-187 9494 108108 300300
실시예 14Example 14 A-79A-79 B-188B-188 9595 109109 250250
실시예 15Example 15 A-158A-158 B-4B-4 9696 101101 367367
실시예 16Example 16 A-158A-158 B-188B-188 9595 106106 300300
실시예 17Example 17 A-166A-166 B-4B-4 9797 101101 350350
실시예 18Example 18 A-166A-166 B-11B-11 9696 104104 300300
실시예 19Example 19 A-166A-166 B-203B-203 9191 100100 300300
비교예 1Comparative Example 1 H1H1 B-4B-4 100100 100100 100100
비교예 2Comparative Example 2 H2H2 B-4B-4 9797 101101 6767
비교예 3Comparative Example 3 H2H2 H3H3 115115 8787 33
비교예 4Comparative Example 4 A-69A-69 H3H3 113113 8989 33
표 2를 참고하면, 본 발명의 실시예에 따른 화합물이 적용된 유기 발광 소자는 비교예에 따른 유기 발광 소자 대비 구동, 효율, 수명 특성이 개선되며, 특히 수명 특성이 현저히 개선된 것을 확인할 수 있다.Referring to Table 2, it can be seen that the organic light emitting device to which the compound according to the embodiment of the present invention is applied has improved drive, efficiency, and lifespan characteristics compared to the organic light emitting device according to the comparative example, and in particular, lifespan characteristics are remarkably improved.
실시예들에 대하여 상세하게 설명하였지만 본 발명의 권리범위는 이에 한정되는 것은 아니고 다음의 청구 범위에서 정의하고 있는 본 발명의 기본 개념을 이용한 당업자의 여러 변형 및 개량 형태 또한 본 발명의 권리범위에 속하는 것이다. Although the embodiments have been described in detail, the scope of the present invention is not limited thereto, and various modifications and improvements of those skilled in the art using the basic concepts of the present invention defined in the following claims also fall within the scope of the present invention. will be.

Claims (13)

  1. 하기 화학식 1로 표시되는 제1 화합물, 및A first compound represented by Formula 1 below, and
    하기 화학식 2로 표시되는 제2 화합물을 포함하는 유기 광전자 소자용 조성물:A composition for an organic optoelectronic device comprising a second compound represented by Formula 2 below:
    [화학식 1][Formula 1]
    Figure PCTKR2023002090-appb-img-000178
    Figure PCTKR2023002090-appb-img-000178
    상기 화학식 1에서,In Formula 1,
    Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,Ar 1 and Ar 2 are each independently a substituted or unsubstituted C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group;
    L1 내지 L3은 각각 독립적으로 단일 결합, 치환 또는 비치환된 C6 내지 C30 아릴렌기 또는 치환 또는 비치환된 C2 내지 C30 헤테로아릴렌기이며,L 1 to L 3 are each independently a single bond, a substituted or unsubstituted C6 to C30 arylene group or a substituted or unsubstituted C2 to C30 heteroarylene group,
    R1 내지 R4는 각각 독립적으로 수소, 중수소, 시아노기, 할로겐기, 치환 또는 비치환된 아민기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,R 1 to R 4 are each independently hydrogen, heavy hydrogen, a cyano group, a halogen group, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or An unsubstituted C2 to C30 heterocyclic group,
    n1은 1 내지 3의 정수 중 하나이고,n1 is an integer from 1 to 3;
    n2 및 n3은 각각 독립적으로 1 또는 2의 정수 중 하나이며,n2 and n3 are each independently an integer of 1 or 2;
    n4는 1 내지 4의 정수 중 하나이고;n4 is an integer from 1 to 4;
    [화학식 2][Formula 2]
    Figure PCTKR2023002090-appb-img-000179
    Figure PCTKR2023002090-appb-img-000179
    상기 화학식 2에서,In Formula 2,
    Ar3 및 Ar4는 각각 독립적으로 치환 또는 비치환된 C6 내지 C20 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,Ar 3 and Ar 4 are each independently a substituted or unsubstituted C6 to C20 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group;
    L4 내지 L6은 각각 독립적으로 단일결합 또는 치환 또는 비치환된 C6 내지 C30 아릴렌기이고, L 4 to L 6 are each independently a single bond or a substituted or unsubstituted C6 to C30 arylene group;
    R5 내지 R9는 각각 독립적으로 수소, 중수소, 시아노기, 할로겐기, 치환 또는 비치환된 아민기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,R 5 to R 9 are each independently hydrogen, heavy hydrogen, a cyano group, a halogen group, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or An unsubstituted C2 to C30 heterocyclic group,
    m1 내지 m3 은 각각 독립적으로 0 또는 1의 정수이고,m1 to m3 are each independently an integer of 0 or 1,
    0 ≤ m1+m2+m3 ≤ 1이며,0 ≤ m1+m2+m3 ≤ 1, and
    n5 내지 n9는 각각 독립적으로 1 내지 4의 정수 중 하나이다.n5 to n9 are each independently an integer of 1 to 4;
  2. 제1항에 있어서,According to claim 1,
    상기 화학식 1은 하기 화학식 1-1 내지 화학식 1-4 중 어느 하나로 표시되는 유기 광전자 소자용 조성물:Formula 1 is a composition for an organic optoelectronic device represented by any one of the following Formulas 1-1 to 1-4:
    [화학식 1-1] [화학식 1-2][Formula 1-1] [Formula 1-2]
    Figure PCTKR2023002090-appb-img-000180
    Figure PCTKR2023002090-appb-img-000180
    [화학식 1-3] [화학식 1-4][Formula 1-3] [Formula 1-4]
    Figure PCTKR2023002090-appb-img-000181
    Figure PCTKR2023002090-appb-img-000181
    상기 화학식 1-1 내지 화학식 1-4에서,In Formula 1-1 to Formula 1-4,
    Ar1, Ar2, L1 내지 L3, R1 내지 R4, 및 n1 내지 n4는 제1항에서 정의한 바와 같다.Ar 1 , Ar 2 , L 1 to L 3 , R 1 to R 4 , and n1 to n4 are as defined in claim 1.
  3. 제1항에 있어서,According to claim 1,
    상기 화학식 1의 Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 터페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 안트라세닐기, 치환 또는 비치환된 페난트레닐기, 치환 또는 비치환된 트리페닐렌기, 치환 또는 비치환된 디벤조퓨란일기, 치환 또는 비치환된 디벤조티오페일기, 치환 또는 비치환된 벤조나프토퓨란일기 또는 치환 또는 비치환된 벤조나프토티오펜일기인, 유기 광전자 소자용 조성물.Ar 1 and Ar 2 in Formula 1 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted terphenyl group, a substituted or unsubstituted naphthyl group, or a substituted or unsubstituted anthrayl group. Cenyl group, substituted or unsubstituted phenanthrenyl group, substituted or unsubstituted triphenylene group, substituted or unsubstituted dibenzofuranyl group, substituted or unsubstituted dibenzothiophenyl group, substituted or unsubstituted benzonaphtho A composition for an organic optoelectronic device comprising a furanyl group or a substituted or unsubstituted benzonaphthothiophenyl group.
  4. 제1항에 있어서,According to claim 1,
    상기 화학식 1의 L1은 단일 결합이고,L 1 of Formula 1 is a single bond,
    *-L2-Ar1 및 *-L3-Ar2는 각각 독립적으로 하기 그룹 Ⅰ에 나열된 치환기 중에서 선택되는 하나인, 유기 광전자 소자용 조성물:*-L 2 -Ar 1 and *-L 3 -Ar 2 are each independently one selected from the substituents listed in Group I below, a composition for an organic optoelectronic device:
    [그룹 Ⅰ] [Group I]
    Figure PCTKR2023002090-appb-img-000182
    Figure PCTKR2023002090-appb-img-000182
    상기 그룹 Ⅰ에서, *은 연결 지점이다.In Group I above, * is a connection point.
  5. 제1항에 있어서,According to claim 1,
    상기 제1 화합물은 하기 그룹 1에 나열된 화합물 중에서 선택되는 하나인 유기 광전자 소자용 조성물:The first compound is a composition for an organic optoelectronic device, wherein the first compound is one selected from compounds listed in Group 1:
    [그룹 1] [Group 1]
    [A-1] [A-2] [A-3] [A-4][A-1] [A-2] [A-3] [A-4]
    Figure PCTKR2023002090-appb-img-000183
    Figure PCTKR2023002090-appb-img-000183
    [A-5] [A-6] [A-7] [A-8][A-5] [A-6] [A-7] [A-8]
    Figure PCTKR2023002090-appb-img-000184
    Figure PCTKR2023002090-appb-img-000184
    [A-9] [A-10] [A-11] [A-12][A-9] [A-10] [A-11] [A-12]
    Figure PCTKR2023002090-appb-img-000185
    Figure PCTKR2023002090-appb-img-000185
    [A-13] [A-14] [A-15] [A-16][A-13] [A-14] [A-15] [A-16]
    Figure PCTKR2023002090-appb-img-000186
    Figure PCTKR2023002090-appb-img-000186
    [A-17] [A-18] [A-19] [A-20][A-17] [A-18] [A-19] [A-20]
    Figure PCTKR2023002090-appb-img-000187
    Figure PCTKR2023002090-appb-img-000187
    [A-21] [A-22] [A-23] [A-24][A-21] [A-22] [A-23] [A-24]
    Figure PCTKR2023002090-appb-img-000188
    Figure PCTKR2023002090-appb-img-000188
    [A-25] [A-26] [A-27] [A-28][A-25] [A-26] [A-27] [A-28]
    Figure PCTKR2023002090-appb-img-000189
    Figure PCTKR2023002090-appb-img-000189
    [A-29] [A-30] [A-31] [A-32][A-29] [A-30] [A-31] [A-32]
    Figure PCTKR2023002090-appb-img-000190
    Figure PCTKR2023002090-appb-img-000190
    [A-33] [A-34] [A-35] [A-36][A-33] [A-34] [A-35] [A-36]
    Figure PCTKR2023002090-appb-img-000191
    Figure PCTKR2023002090-appb-img-000191
    [A-37] [A-38] [A-39] [A-40][A-37] [A-38] [A-39] [A-40]
    Figure PCTKR2023002090-appb-img-000192
    Figure PCTKR2023002090-appb-img-000192
    [A-41] [A-42] [A-43] [A-44][A-41] [A-42] [A-43] [A-44]
    Figure PCTKR2023002090-appb-img-000193
    Figure PCTKR2023002090-appb-img-000193
    [A-45] [A-46] [A-47] [A-48][A-45] [A-46] [A-47] [A-48]
    Figure PCTKR2023002090-appb-img-000194
    Figure PCTKR2023002090-appb-img-000194
    [A-49] [A-50] [A-51] [A-52][A-49] [A-50] [A-51] [A-52]
    Figure PCTKR2023002090-appb-img-000195
    Figure PCTKR2023002090-appb-img-000195
    [A-53] [A-54] [A-55] [A-56][A-53] [A-54] [A-55] [A-56]
    Figure PCTKR2023002090-appb-img-000196
    Figure PCTKR2023002090-appb-img-000196
    [A-57] [A-58] [A-59] [A-60][A-57] [A-58] [A-59] [A-60]
    Figure PCTKR2023002090-appb-img-000197
    Figure PCTKR2023002090-appb-img-000197
    [A-61] [A-62] [A-63] [A-64][A-61] [A-62] [A-63] [A-64]
    Figure PCTKR2023002090-appb-img-000198
    Figure PCTKR2023002090-appb-img-000198
    [A-65] [A-66] [A-67] [A-68][A-65] [A-66] [A-67] [A-68]
    Figure PCTKR2023002090-appb-img-000199
    Figure PCTKR2023002090-appb-img-000199
    [A-69] [A-70] [A-71] [A-72][A-69] [A-70] [A-71] [A-72]
    Figure PCTKR2023002090-appb-img-000200
    Figure PCTKR2023002090-appb-img-000200
    [A-73] [A-74] [A-75] [A-76][A-73] [A-74] [A-75] [A-76]
    Figure PCTKR2023002090-appb-img-000201
    Figure PCTKR2023002090-appb-img-000201
    [A-77] [A-78] [A-79] [A-80][A-77] [A-78] [A-79] [A-80]
    Figure PCTKR2023002090-appb-img-000202
    Figure PCTKR2023002090-appb-img-000202
    [A-81] [A-82] [A-83] [A-84][A-81] [A-82] [A-83] [A-84]
    Figure PCTKR2023002090-appb-img-000203
    Figure PCTKR2023002090-appb-img-000203
    [A-85] [A-86] [A-87] [A-88][A-85] [A-86] [A-87] [A-88]
    Figure PCTKR2023002090-appb-img-000204
    Figure PCTKR2023002090-appb-img-000204
    [A-89] [A-90] [A-91] [A-92][A-89] [A-90] [A-91] [A-92]
    Figure PCTKR2023002090-appb-img-000205
    Figure PCTKR2023002090-appb-img-000205
    [A-93] [A-94] [A-95] [A-96][A-93] [A-94] [A-95] [A-96]
    Figure PCTKR2023002090-appb-img-000206
    Figure PCTKR2023002090-appb-img-000206
    [A-97] [A-98] [A-99] [A-100][A-97] [A-98] [A-99] [A-100]
    Figure PCTKR2023002090-appb-img-000207
    Figure PCTKR2023002090-appb-img-000207
    [A-101] [A-102] [A-103] [A-104][A-101] [A-102] [A-103] [A-104]
    Figure PCTKR2023002090-appb-img-000208
    Figure PCTKR2023002090-appb-img-000208
    [A-105] [A-106] [A-107] [A-108][A-105] [A-106] [A-107] [A-108]
    Figure PCTKR2023002090-appb-img-000209
    Figure PCTKR2023002090-appb-img-000209
    [A-109] [A-110] [A-111] [A-112][A-109] [A-110] [A-111] [A-112]
    Figure PCTKR2023002090-appb-img-000210
    Figure PCTKR2023002090-appb-img-000210
    [A-113] [A-114] [A-115] [A-116][A-113] [A-114] [A-115] [A-116]
    Figure PCTKR2023002090-appb-img-000211
    Figure PCTKR2023002090-appb-img-000211
    [A-117] [A-118] [A-119] [A-120][A-117] [A-118] [A-119] [A-120]
    Figure PCTKR2023002090-appb-img-000212
    Figure PCTKR2023002090-appb-img-000212
    [A-121] [A-122] [A-123] [A-124][A-121] [A-122] [A-123] [A-124]
    Figure PCTKR2023002090-appb-img-000213
    Figure PCTKR2023002090-appb-img-000213
    [A-125] [A-126] [A-127] [A-128][A-125] [A-126] [A-127] [A-128]
    Figure PCTKR2023002090-appb-img-000214
    Figure PCTKR2023002090-appb-img-000214
    [A-129] [A-130] [A-131] [A-132][A-129] [A-130] [A-131] [A-132]
    Figure PCTKR2023002090-appb-img-000215
    Figure PCTKR2023002090-appb-img-000215
    [A-133] [A-134] [A-135] [A-136][A-133] [A-134] [A-135] [A-136]
    Figure PCTKR2023002090-appb-img-000216
    Figure PCTKR2023002090-appb-img-000216
    [A-137] [A-138] [A-139] [A-140][A-137] [A-138] [A-139] [A-140]
    Figure PCTKR2023002090-appb-img-000217
    Figure PCTKR2023002090-appb-img-000217
    [A-141] [A-142] [A-143] [A-144][A-141] [A-142] [A-143] [A-144]
    Figure PCTKR2023002090-appb-img-000218
    Figure PCTKR2023002090-appb-img-000218
    [A-145] [A-146] [A-147] [A-148][A-145] [A-146] [A-147] [A-148]
    Figure PCTKR2023002090-appb-img-000219
    Figure PCTKR2023002090-appb-img-000219
    [A-149] [A-150] [A-151] [A-152][A-149] [A-150] [A-151] [A-152]
    Figure PCTKR2023002090-appb-img-000220
    Figure PCTKR2023002090-appb-img-000220
    [A-153] [A-154] [A-155] [A-156][A-153] [A-154] [A-155] [A-156]
    Figure PCTKR2023002090-appb-img-000221
    Figure PCTKR2023002090-appb-img-000221
    [A-157] [A-158] [A-159] [A-160][A-157] [A-158] [A-159] [A-160]
    Figure PCTKR2023002090-appb-img-000222
    Figure PCTKR2023002090-appb-img-000222
    [A-161] [A-162] [A-163] [A-164][A-161] [A-162] [A-163] [A-164]
    Figure PCTKR2023002090-appb-img-000223
    Figure PCTKR2023002090-appb-img-000223
    [A-165] [A-166] [A-167] [A-168][A-165] [A-166] [A-167] [A-168]
    Figure PCTKR2023002090-appb-img-000224
    .
    Figure PCTKR2023002090-appb-img-000224
    .
  6. 제1항에 있어서,According to claim 1,
    상기 화학식 2는 하기 화학식 2A 내지 화학식 2D 중 어느 하나로 표시되는 유기 광전자 소자용 조성물:Formula 2 is a composition for an organic optoelectronic device represented by any one of Formulas 2A to 2D:
    [화학식 2A] [화학식 2B][Formula 2A] [Formula 2B]
    Figure PCTKR2023002090-appb-img-000225
    Figure PCTKR2023002090-appb-img-000225
    [화학식 2C] [화학식 2D][Formula 2C] [Formula 2D]
    Figure PCTKR2023002090-appb-img-000226
    Figure PCTKR2023002090-appb-img-000226
    상기 화학식 2A 내지 화학식 2D 에서,In Formulas 2A to 2D,
    Ar3, Ar4, L4 내지 L6, R6 내지 R9, 및 n6 내지 n9는 제1항에서 정의한 바와 같고,Ar 3 , Ar 4 , L 4 to L 6 , R 6 to R 9 , and n6 to n9 are as defined in claim 1,
    R5a 및 R5b는 각각 독립적으로 각각 독립적으로 수소, 중수소, 시아노기, 할로겐기, 치환 또는 비치환된 아민기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이다.R 5a and R 5b are each independently selected from hydrogen, heavy hydrogen, a cyano group, a halogen group, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, or a substituted or unsubstituted C6 to C30 aryl group. Or a substituted or unsubstituted C2 to C30 heterocyclic group.
  7. 제1항에 있어서,According to claim 1,
    상기 화학식 2의 Ar3 및 Ar4는 각각 독립적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 터페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 안트라세닐기, 치환 또는 비치환된 페난트레닐기, 치환 또는 비치환된 트리페닐렌기, 치환 또는 비치환된 디벤조퓨란일기, 치환 또는 비치환된 디벤조티오펜일기, 치환 또는 비치환된 치환 또는 비치환된 벤조나프토퓨란일기 또는 치환 또는 비치환된 벤조나프토티오펜일기인, 유기 광전자 소자용 조성물.Ar 3 and Ar 4 in Formula 2 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted terphenyl group, a substituted or unsubstituted naphthyl group, or a substituted or unsubstituted anthrayl group. Cenyl group, substituted or unsubstituted phenanthrenyl group, substituted or unsubstituted triphenylene group, substituted or unsubstituted dibenzofuranyl group, substituted or unsubstituted dibenzothiophenyl group, substituted or unsubstituted substituted or unsubstituted dibenzofuranyl group, A composition for an organic optoelectronic device, which is a substituted benzonaphthofuranyl group or a substituted or unsubstituted benzonaphthothiophenyl group.
  8. 제1항에 있어서,According to claim 1,
    상기 화학식 2의 L4는 단일결합이고,L 4 of Formula 2 is a single bond;
    *-L5-Ar3 및 *-L6-Ar4는 각각 독립적으로 하기 그룹 Ⅱ에 나열된 치환기 중에서 선택되는 하나인, 유기 광전자 소자용 조성물:*-L 5 -Ar 3 and *-L 6 -Ar 4 are each independently one selected from the substituents listed in Group II below, composition for an organic optoelectronic device:
    [그룹 Ⅱ][Group II]
    Figure PCTKR2023002090-appb-img-000227
    Figure PCTKR2023002090-appb-img-000227
    상기 그룹 Ⅱ에서, *은 연결 지점이다.In Group II above, * is a connection point.
  9. 제1항에 있어서,According to claim 1,
    상기 제2 화합물은 하기 그룹 2에 나열된 화합물 중에서 선택되는 하나인 유기 광전자 소자용 조성물:The second compound is a composition for an organic optoelectronic device in which one selected from the compounds listed in Group 2 below:
    [그룹 2][Group 2]
    [B-1] [B-2] [B-3] [B-4][B-1] [B-2] [B-3] [B-4]
    Figure PCTKR2023002090-appb-img-000228
    Figure PCTKR2023002090-appb-img-000228
    [B-5] [B-6] [B-7] [B-8][B-5] [B-6] [B-7] [B-8]
    Figure PCTKR2023002090-appb-img-000229
    Figure PCTKR2023002090-appb-img-000229
    [B-9] [B-10] [B-11] [B-12][B-9] [B-10] [B-11] [B-12]
    Figure PCTKR2023002090-appb-img-000230
    Figure PCTKR2023002090-appb-img-000230
    [B-13] [B-14] [B-15] [B-16][B-13] [B-14] [B-15] [B-16]
    Figure PCTKR2023002090-appb-img-000231
    Figure PCTKR2023002090-appb-img-000231
    [B-17] [B-18] [B-19] [B-20][B-17] [B-18] [B-19] [B-20]
    Figure PCTKR2023002090-appb-img-000232
    Figure PCTKR2023002090-appb-img-000232
    [B-21] [B-22] [B-23] [B-24][B-21] [B-22] [B-23] [B-24]
    Figure PCTKR2023002090-appb-img-000233
    Figure PCTKR2023002090-appb-img-000233
    [B-25] [B-26] [B-27] [B-28][B-25] [B-26] [B-27] [B-28]
    Figure PCTKR2023002090-appb-img-000234
    Figure PCTKR2023002090-appb-img-000234
    [B-29] [B-30] [B-31] [B-32][B-29] [B-30] [B-31] [B-32]
    Figure PCTKR2023002090-appb-img-000235
    Figure PCTKR2023002090-appb-img-000235
    [B-33] [B-34] [B-35] [B-36][B-33] [B-34] [B-35] [B-36]
    Figure PCTKR2023002090-appb-img-000236
    Figure PCTKR2023002090-appb-img-000236
    [B-37] [B-38] [B-39] [B-40][B-37] [B-38] [B-39] [B-40]
    Figure PCTKR2023002090-appb-img-000237
    Figure PCTKR2023002090-appb-img-000237
    [B-41] [B-42] [B-43] [B-44][B-41] [B-42] [B-43] [B-44]
    Figure PCTKR2023002090-appb-img-000238
    Figure PCTKR2023002090-appb-img-000238
    [B-45] [B-46] [B-47] [B-48][B-45] [B-46] [B-47] [B-48]
    Figure PCTKR2023002090-appb-img-000239
    Figure PCTKR2023002090-appb-img-000239
    [B-49] [B-50] [B-51] [B-52][B-49] [B-50] [B-51] [B-52]
    Figure PCTKR2023002090-appb-img-000240
    Figure PCTKR2023002090-appb-img-000240
    [B-53] [B-54] [B-55] [B-56] [B-53] [B-54] [B-55] [B-56]
    Figure PCTKR2023002090-appb-img-000241
    Figure PCTKR2023002090-appb-img-000241
    [B-57] [B-58] [B-59] [B-60][B-57] [B-58] [B-59] [B-60]
    Figure PCTKR2023002090-appb-img-000242
    Figure PCTKR2023002090-appb-img-000242
    [B-61] [B-62] [B-63] [B-64][B-61] [B-62] [B-63] [B-64]
    Figure PCTKR2023002090-appb-img-000243
    Figure PCTKR2023002090-appb-img-000243
    [B-65] [B-66] [B-67] [B-68][B-65] [B-66] [B-67] [B-68]
    Figure PCTKR2023002090-appb-img-000244
    Figure PCTKR2023002090-appb-img-000244
    [B-69] [B-70] [B-71] [B-72][B-69] [B-70] [B-71] [B-72]
    Figure PCTKR2023002090-appb-img-000245
    Figure PCTKR2023002090-appb-img-000245
    [B-73] [B-74] [B-75] [B-76][B-73] [B-74] [B-75] [B-76]
    Figure PCTKR2023002090-appb-img-000246
    Figure PCTKR2023002090-appb-img-000246
    [B-77] [B-78] [B-79] [B-80][B-77] [B-78] [B-79] [B-80]
    Figure PCTKR2023002090-appb-img-000247
    Figure PCTKR2023002090-appb-img-000247
    [B-81] [B-82] [B-83] [B-84][B-81] [B-82] [B-83] [B-84]
    Figure PCTKR2023002090-appb-img-000248
    Figure PCTKR2023002090-appb-img-000248
    [B-85] [B-86] [B-87] [B-88][B-85] [B-86] [B-87] [B-88]
    Figure PCTKR2023002090-appb-img-000249
    Figure PCTKR2023002090-appb-img-000249
    [B-89] [B-90] [B-91] [B-92][B-89] [B-90] [B-91] [B-92]
    Figure PCTKR2023002090-appb-img-000250
    Figure PCTKR2023002090-appb-img-000250
    [B-93] [B-94] [B-95] [B-96][B-93] [B-94] [B-95] [B-96]
    Figure PCTKR2023002090-appb-img-000251
    Figure PCTKR2023002090-appb-img-000251
    [B-97] [B-98] [B-99] [B-100][B-97] [B-98] [B-99] [B-100]
    Figure PCTKR2023002090-appb-img-000252
    Figure PCTKR2023002090-appb-img-000252
    [B-101] [B-102] [B-103] [B-104][B-101] [B-102] [B-103] [B-104]
    Figure PCTKR2023002090-appb-img-000253
    Figure PCTKR2023002090-appb-img-000253
    [B-105] [B-106] [B-107] [B-108][B-105] [B-106] [B-107] [B-108]
    Figure PCTKR2023002090-appb-img-000254
    Figure PCTKR2023002090-appb-img-000254
    [B-109] [B-110] [B-111] [B-112][B-109] [B-110] [B-111] [B-112]
    Figure PCTKR2023002090-appb-img-000255
    Figure PCTKR2023002090-appb-img-000255
    [B-113] [B-114] [B-115] [B-116][B-113] [B-114] [B-115] [B-116]
    Figure PCTKR2023002090-appb-img-000256
    Figure PCTKR2023002090-appb-img-000256
    [B-117] [B-118] [B-119] [B-120][B-117] [B-118] [B-119] [B-120]
    Figure PCTKR2023002090-appb-img-000257
    Figure PCTKR2023002090-appb-img-000257
    [B-121] [B-122] [B-123] [B-124][B-121] [B-122] [B-123] [B-124]
    Figure PCTKR2023002090-appb-img-000258
    Figure PCTKR2023002090-appb-img-000258
    [B-125] [B-126] [B-127] [B-128][B-125] [B-126] [B-127] [B-128]
    Figure PCTKR2023002090-appb-img-000259
    Figure PCTKR2023002090-appb-img-000259
    [B-129] [B-130] [B-131] [B-132][B-129] [B-130] [B-131] [B-132]
    Figure PCTKR2023002090-appb-img-000260
    Figure PCTKR2023002090-appb-img-000260
    [B-133] [B-134] [B-135] [B-136][B-133] [B-134] [B-135] [B-136]
    Figure PCTKR2023002090-appb-img-000261
    Figure PCTKR2023002090-appb-img-000261
    [B-137] [B-138] [B-139] [B-140][B-137] [B-138] [B-139] [B-140]
    Figure PCTKR2023002090-appb-img-000262
    Figure PCTKR2023002090-appb-img-000262
    [B-141] [B-142] [B-143] [B-144][B-141] [B-142] [B-143] [B-144]
    Figure PCTKR2023002090-appb-img-000263
    Figure PCTKR2023002090-appb-img-000263
    [B-145] [B-146] [B-147] [B-148][B-145] [B-146] [B-147] [B-148]
    Figure PCTKR2023002090-appb-img-000264
    Figure PCTKR2023002090-appb-img-000264
    [B-149] [B-150] [B-151] [B-152][B-149] [B-150] [B-151] [B-152]
    Figure PCTKR2023002090-appb-img-000265
    Figure PCTKR2023002090-appb-img-000265
    [B-153] [B-154] [B-155] [B-156][B-153] [B-154] [B-155] [B-156]
    Figure PCTKR2023002090-appb-img-000266
    Figure PCTKR2023002090-appb-img-000266
    [B-157] [B-158] [B-159] [B-160][B-157] [B-158] [B-159] [B-160]
    Figure PCTKR2023002090-appb-img-000267
    Figure PCTKR2023002090-appb-img-000267
    [B-161] [B-162] [B-163] [B-164][B-161] [B-162] [B-163] [B-164]
    Figure PCTKR2023002090-appb-img-000268
    Figure PCTKR2023002090-appb-img-000268
    [B-165] [B-166] [B-167] [B-168][B-165] [B-166] [B-167] [B-168]
    Figure PCTKR2023002090-appb-img-000269
    Figure PCTKR2023002090-appb-img-000269
    [B-169] [B-170] [B-171] [B-172][B-169] [B-170] [B-171] [B-172]
    Figure PCTKR2023002090-appb-img-000270
    Figure PCTKR2023002090-appb-img-000270
    [B-173] [B-174] [B-175] [B-176][B-173] [B-174] [B-175] [B-176]
    Figure PCTKR2023002090-appb-img-000271
    Figure PCTKR2023002090-appb-img-000271
    [B-177] [B-178] [B-179] [B-180][B-177] [B-178] [B-179] [B-180]
    Figure PCTKR2023002090-appb-img-000272
    Figure PCTKR2023002090-appb-img-000272
    [B-181] [B-182] [B-183] [B-184][B-181] [B-182] [B-183] [B-184]
    Figure PCTKR2023002090-appb-img-000273
    Figure PCTKR2023002090-appb-img-000273
    [B-185] [B-186] [B-187] [B-188][B-185] [B-186] [B-187] [B-188]
    Figure PCTKR2023002090-appb-img-000274
    Figure PCTKR2023002090-appb-img-000274
    [B-189] [B-190] [B-191] [B-192][B-189] [B-190] [B-191] [B-192]
    Figure PCTKR2023002090-appb-img-000275
    Figure PCTKR2023002090-appb-img-000275
    [B-193] [B-194] [B-195] [B-196][B-193] [B-194] [B-195] [B-196]
    Figure PCTKR2023002090-appb-img-000276
    Figure PCTKR2023002090-appb-img-000276
    [B-197] [B-198] [B-199] [B-200][B-197] [B-198] [B-199] [B-200]
    Figure PCTKR2023002090-appb-img-000277
    Figure PCTKR2023002090-appb-img-000277
    [B-201] [B-202] [B-203] [B-204][B-201] [B-202] [B-203] [B-204]
    Figure PCTKR2023002090-appb-img-000278
    Figure PCTKR2023002090-appb-img-000278
    [B-205] [B-206] [B-207] [B-208][B-205] [B-206] [B-207] [B-208]
    Figure PCTKR2023002090-appb-img-000279
    Figure PCTKR2023002090-appb-img-000279
  10. 제1항에 있어서,According to claim 1,
    상기 제1 화합물은 하기 화학식 1-2로 표시되고,The first compound is represented by Formula 1-2 below,
    상기 제2 화합물은 하기 화학식 2B 내지 화학식 2D 중 어느 하나로 표시되는, 유기 광전자 소자용 조성물:The second compound is a composition for an organic optoelectronic device represented by any one of Formulas 2B to 2D:
    [화학식 1-2][Formula 1-2]
    Figure PCTKR2023002090-appb-img-000280
    Figure PCTKR2023002090-appb-img-000280
    상기 화학식 1-2에서,In Formula 1-2,
    Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 디벤조퓨란일기, 치환 또는 비치환된 디벤조티오페일기, 치환 또는 비치환된 벤조나프토퓨란일기 또는 치환 또는 비치환된 벤조나프토티오펜일기이고,Ar 1 and Ar 2 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted dibenzofuranyl group, or a substituted or unsubstituted dibenzothione group. An opayl group, a substituted or unsubstituted benzonaphthofuranyl group, or a substituted or unsubstituted benzonaphthothiophenyl group,
    L1 은 단일 결합이고,L 1 is a single bond;
    L2 및 L3은 각각 독립적으로 단일 결합, 치환 또는 비치환된 페닐렌기 또는 치환 또는 비치환된 나프틸렌기이고, L 2 and L 3 are each independently a single bond, a substituted or unsubstituted phenylene group or a substituted or unsubstituted naphthylene group,
    R1 내지 R4는 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C10 알킬기 또는 치환 또는 비치환된 C6 내지 C12 아릴기이고,R 1 to R 4 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group or a substituted or unsubstituted C6 to C12 aryl group,
    n1 내지 n4는 0 또는 1의 정수이며;n1 to n4 are integers of 0 or 1;
    [화학식 2B][Formula 2B]
    Figure PCTKR2023002090-appb-img-000281
    Figure PCTKR2023002090-appb-img-000281
    [화학식 2C] [화학식 2D][Formula 2C] [Formula 2D]
    Figure PCTKR2023002090-appb-img-000282
    Figure PCTKR2023002090-appb-img-000282
    상기 화학식 2B 내지 화학식 2D 에서,In Formulas 2B to 2D,
    Ar3 및 Ar4는 각각 독립적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 디벤조퓨란일기, 치환 또는 비치환된 디벤조티오페일기, 치환 또는 비치환된 벤조나프토퓨란일기 또는 치환 또는 비치환된 벤조나프토티오펜일기이고,Ar 3 and Ar 4 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted dibenzofuranyl group, or a substituted or unsubstituted dibenzothio group. An opayl group, a substituted or unsubstituted benzonaphthofuranyl group, or a substituted or unsubstituted benzonaphthothiophenyl group,
    L4는 단일 결합이고,L 4 is a single bond;
    L5 및 L6은 각각 독립적으로 단일 결합, 치환 또는 비치환된 페닐렌기 또는 치환 또는 비치환된 나프틸렌기이고,L 5 and L 6 are each independently a single bond, a substituted or unsubstituted phenylene group or a substituted or unsubstituted naphthylene group,
    R6 내지 R9 및 R5a 및 R5b는 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C10 알킬기, 또는 치환 또는 비치환된 C6 내지 C12 아릴기이고,R 6 to R 9 and R 5a and R 5b are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, or a substituted or unsubstituted C6 to C12 aryl group;
    n6 내지 n9는 각각 독립적으로 0 또는 1의 정수이다.n6 to n9 are each independently an integer of 0 or 1;
  11. 서로 마주하는 양극과 음극,anode and cathode facing each other,
    상기 양극과 상기 음극 사이에 위치하는 적어도 1층의 유기층을 포함하고,At least one organic layer positioned between the anode and the cathode,
    상기 유기층은 제1항 내지 제10항 중 어느 한 항에 따른 유기 광전자 소자용 조성물을 포함하는 유기 광전자 소자.The organic layer is an organic optoelectronic device comprising the composition for an organic optoelectronic device according to any one of claims 1 to 10.
  12. 제11항에 있어서,According to claim 11,
    상기 유기층은 발광층을 포함하고,The organic layer includes a light emitting layer,
    상기 발광층은 상기 유기 광전자 소자용 조성물을 포함하는 유기 광전자 소자.The light emitting layer is an organic optoelectronic device comprising the composition for the organic optoelectronic device.
  13. 제11항에 따른 유기 광전자 소자를 포함하는 표시 장치.A display device comprising the organic optoelectronic device according to claim 11 .
PCT/KR2023/002090 2022-02-14 2023-02-14 Composition for organic optoelectronic diode, organic optoelectronic diode, and display device WO2023153905A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020220019080A KR20230122424A (en) 2022-02-14 2022-02-14 Composition for organic optoelectronic device, organic optoelectronic device and display device
KR10-2022-0019080 2022-02-14

Publications (1)

Publication Number Publication Date
WO2023153905A1 true WO2023153905A1 (en) 2023-08-17

Family

ID=87564806

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2023/002090 WO2023153905A1 (en) 2022-02-14 2023-02-14 Composition for organic optoelectronic diode, organic optoelectronic diode, and display device

Country Status (2)

Country Link
KR (1) KR20230122424A (en)
WO (1) WO2023153905A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011060878A (en) * 2009-09-08 2011-03-24 Konica Minolta Holdings Inc Organic electroluminescent element, display device and lighting device
KR20120123353A (en) * 2009-12-21 2012-11-08 이 아이 듀폰 디 네모아 앤드 캄파니 Electroactive composition and electronic device made with the composition
KR20150137400A (en) * 2014-05-29 2015-12-09 덕산네오룩스 주식회사 Organic electronic element using a compound for organic electronic element, and an electronic device thereof
CN108586188A (en) * 2018-06-01 2018-09-28 石家庄诚志永华显示材料有限公司 * derivative, material and organic electroluminescence device comprising the * derivatives
KR20210098316A (en) * 2020-01-31 2021-08-10 롬엔드하스전자재료코리아유한회사 Organic electroluminescent compound, a plurality of host materials, and organic electroluminescent device comprising the same
KR20220118960A (en) * 2021-02-19 2022-08-26 주식회사 엘지화학 Organic light emitting device

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011060878A (en) * 2009-09-08 2011-03-24 Konica Minolta Holdings Inc Organic electroluminescent element, display device and lighting device
KR20120123353A (en) * 2009-12-21 2012-11-08 이 아이 듀폰 디 네모아 앤드 캄파니 Electroactive composition and electronic device made with the composition
KR20150137400A (en) * 2014-05-29 2015-12-09 덕산네오룩스 주식회사 Organic electronic element using a compound for organic electronic element, and an electronic device thereof
CN108586188A (en) * 2018-06-01 2018-09-28 石家庄诚志永华显示材料有限公司 * derivative, material and organic electroluminescence device comprising the * derivatives
KR20210098316A (en) * 2020-01-31 2021-08-10 롬엔드하스전자재료코리아유한회사 Organic electroluminescent compound, a plurality of host materials, and organic electroluminescent device comprising the same
KR20220118960A (en) * 2021-02-19 2022-08-26 주식회사 엘지화학 Organic light emitting device

Also Published As

Publication number Publication date
KR20230122424A (en) 2023-08-22

Similar Documents

Publication Publication Date Title
WO2013094951A1 (en) Compound for organic optoelectronic device, organic light-emitting diode containing same, and display device comprising organic light-emitting diode
WO2013100464A1 (en) Compound for an organic optoelectronic element, organic light-emitting element comprising same, and display device comprising the organic light-emitting element
WO2016153283A1 (en) Organic light-emitting compound, ink composition, organic light-emitting diode, and electronic device
WO2013100538A1 (en) Compound for organic optoelectric device, organic light emitting element including same, and display device including said organic light emitting element
WO2013100539A9 (en) Compound for organic optoelectronic device, organic light emitting element including same, and display device including said organic light emitting element
WO2019164327A1 (en) Organic light-emitting device
WO2014030822A1 (en) Compound for organic optoelectronic element, organic light-emitting element comprising same, and display device comprising the organic light-emitting element
WO2019139419A1 (en) Organic light-emitting diode
WO2010062065A2 (en) Novel nitrogen-containing heterocyclic compound and organic electronic device using the same
WO2013100467A1 (en) Compound for organic optoelectric device, organic light-emitting diode including same, and display device including organic light-emitting diode
WO2014058123A1 (en) Compound for organic optoelectric device, organic light emitting diode comprising same, and display device comprising organic light emitting diode
EP3371182A1 (en) Electron buffering materials, electron transport materials and organic electroluminescent device comprising the same
WO2013100540A1 (en) Compound for organic optoelectronic device, organic light emitting device containing same, and display device containing said organic light emitting device
WO2019212287A1 (en) Compound and organic light emitting diode comprising same
WO2021107359A1 (en) Compound and organic light emitting device comprising same
WO2013095039A1 (en) Compound for an organic optoelectronic device, organic light-emitting element comprising same, and display device comprising the organic light-emitting element
WO2019059611A1 (en) Organic light emitting element
WO2013100465A1 (en) Compound for organic optoelectronic element, organic light-emitting element comprising same, and display device comprising the organic light-emitting element
WO2019135665A1 (en) Organic light emitting device
WO2022139525A1 (en) Organic light-emitting device including organic compound
WO2021215669A1 (en) Organic optoelectronic element compound, organic optoelectronic element composition, organic optoelectronic element, and display device
WO2022211594A1 (en) Composition for organic optoelectronic device, organic optoelectronic device, and display device
WO2021020929A1 (en) Compound and organic light emitting device comprising same
WO2023282617A2 (en) Composition for organic optoelectronic diode, organic optoelectronic diode, and display device
WO2023008895A1 (en) Organic compound and organic light-emitting device comprising same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23753251

Country of ref document: EP

Kind code of ref document: A1